Sphere 3D (ANY) 10-Q 16 Nov 20 2020 Q3 Quarterly report Financial data

Document Entity Information Doc

Document Entity Information Document - shares	9 Months Ended
	Sep. 30, 2020	Nov. 10, 2020
Document Information [Abstract]
Entity Registrant Name	Sphere 3D Corp.
Entity Central Index Key	0001591956
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity File Number	001-36532
Entity Incorporation, State or Country Code	ON
Entity Tax Identification Number	98-1220792
Entity Address, Address Line One	895 Don Mills Road, Bldg. 2, Suite 900
Entity Address, City or Town	Toronto
Entity Address, Postal Zip Code	M3C 1W3
City Area Code	(858)
Local Phone Number	751-5555
Amendment Flag	false
Entity Common Stock, Shares Outstanding		7,867,186
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Emerging Growth Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Trading Symbol	ANY
Entity Incorporation, State or Country Code	A6
Security Exchange Name	NASDAQ
Title of 12(b) Security	Common Shares

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue	$ 890	$ 1,368	$ 2,791	$ 4,461
Cost of revenue	356	883	1,352	3,036
Gross Profit	534	485	1,439	1,425
Sales and Marketing	336	550	872	1,494
Research and Development	264	460	947	1,673
General and Administrative	1,590	801	4,406	2,814
Operating Expenses	2,190	1,811	6,225	5,981
Loss from Operations	(1,656)	(1,326)	(4,786)	(4,556)
Other income (expense)
Interest Expense, Related Party	(191)	(41)	(309)	(327)
Interest Expense	(57)	(9)	(142)	(24)
Other income, net	715	2,261	1,002	2,283
Income (Loss) Attributable to Parent, before Tax	(1,189)	885	(4,235)	(2,624)
Income Tax Expense (Benefit)	1	0	4	0
Net (loss) income	$ (1,190)	$ 885	$ (4,239)	$ (2,624)
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.17)	$ 0.33	$ (0.81)	$ (1.09)
Income (Loss) from Continuing Operations, Per Diluted Share	$ (0.17)	$ 0.10	$ (0.81)	$ (1.09)
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted Average Number of Shares Outstanding, Basic and Diluted	6,949,010	2,668,311	5,240,003	2,403,373
Weighted Average Number of Shares Outstanding, Diluted	6,949,010	8,909,761	5,240,003	2,403,373

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) Statement - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net (loss) income	$ (1,190)	$ 885	$ (4,239)	$ (2,624)
Other Comprehensive Income (Loss)
Foreign currency translation adjustment	12	(8)	(31)	34
Total other comprehensive income (loss)	12	(8)	(31)	34
Comprehensive (Loss) Income	$ (1,178)	$ 877	$ (4,270)	$ (2,590)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Cash and Cash Equivalents	$ 2,896,000	$ 149,000
Accounts receivable, net	259,000	369,000
Inventories	659,000	753,000
Other Current Assets	998,000	670,000
Assets, Current	4,812,000	1,941,000
Investment in affiliate	2,100,000	2,100,000
Intangible Assets, Net	3,091,000	2,301,000
Goodwill	1,385,000	1,385,000
Other Assets	3,636,000	679,000
Total Assets	15,024,000	8,406,000
Accounts Payable	2,360,000	4,113,000
Accrued Liabilities	2,457,000	475,000
Accrued Payroll and Employee Compensation	405,000	340,000
Deferred Revenue	719,000	1,069,000
Secured Debt, Current	1,103,000	0
Notes Payable, Related Parties, Current	311,000	0
Line of credit	489,000	491,000
Other Current Liabilities	153,000	158,000
Liabilities, Current	7,997,000	6,646,000
Deferred Revenue, long-term	283,000	485,000
Long-term Debt	667,000	0
Other Non-current Liabilities	45,000	35,000
Total Liabilities	8,992,000	7,166,000
Commitments and Contingencies (Note 13)
Preferred shares, no par value, unlimited shares authorized, 9,355,778 and 8,443,778 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	11,769,000	8,444,000
Common shares, no par value; unlimited shares authorized, 7,597,186 and 3,850,105 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	191,898,000	186,161,000
Accumulated Other Comprehensive Loss	(1,800,000)	(1,769,000)
Accumulated Deficit	(195,835,000)	(191,596,000)
Total Shareholders' Equity	6,032,000	1,240,000
Total Liabilities and Shareholders' Equity	$ 15,024,000	$ 8,406,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets Consolidated Balance Sheets Parenthetical Data - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred Stock, No Par Value	$ 0	$ 0
Preferred Shares, Outstanding	9,355,778	8,443,778
Common Shares, No Par Value	$ 0	$ 0
Common Shares, Issued	7,597,186	3,850,105
Common Shares, Outstanding	7,597,186	3,850,105

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating Activities [Abstract]
Net Loss	$ (4,239,000)	$ (2,624,000)
Adjustments to reconcile net loss to cash used in operating activities:
Liability forgiveness	(776,000)	(551,000)
Liability forgiveness related party	0	(1,745,000)
Depreciation and Amortization	742,000	773,000
Revaluation of subscription agreements	(79,000)	0
Amortization of Debt Issuance Costs and Discounts	392,000	0
Share-based Payment Arrangement, Noncash Expense	5,000	478,000
Preferred shares interest expense, related party	0	291,000
Changes in operating assets and liabilities:
Accounts Receivable	110,000	365,000
Inventories	94,000	405,000
Accounts Payable and Accrued Liabilities	3,380,000	454,000
Accrued Payroll and Employee Compensation	66,000	84,000
Deferred Revenue	(553,000)	70,000
Other Assets and Liabilities, Net	(1,138,000)	564,000
Net Cash Used in Operating Activities	(1,996,000)	(1,436,000)
Financing activities:
Proceeds from Issuance of Preferred Stock and Preference Stock	2,735,000	0
Proceeds from Issuance of Unsecured Debt	667,000	0
Proceeds from Convertible Debt	375,000	0
Proceeds from Related Party Convertible Debt	200,000	0
Proceeds from Warrant Exercises	120,000	0
Proceeds from Issuance of Common Stock	115,000	480,000
Proceeds from Stock Options Exercised	76,000	0
Proceeds from debt-related party	500,000	523,000
Increase (Decrease) in Notes Payable, Related Parties, Current	(42,000)	0
Proceeds from (Repayments of) Lines of Credit	(2,000)	221,000
Net Cash Provided by Financing Activities	4,744,000	1,224,000
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(1,000)	0
Net Increase (Decrease) in cash and cash equivalents	2,747,000	(212,000)
Cash, Cash Equivalents, Beginning	149,000	341,000
Cash, Cash Equivalents, Ending	$ 2,896,000	$ 129,000

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows Supplemental Disclosures of Cash Flow Information - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	$ 25,000	$ 32,000
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Issuance of common shares for settlement of liabilities	2,034,000	105,000
Noncash or Part Noncash Acquisition, Value of Assets Acquired	1,560,000	0
Debt Conversion, Converted Instrument, Amount	783,000	0
Conversion of Stock, Amount Issued	510,000	0
Convertible debt issued for prepaid services	150,000	0
Issuance of common shares for settlement of related party liabilities	$ 379,000	$ 529,000

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Equity (Deficit) Statement - USD ($) $ in Thousands	Total	Preferred Shares [Member]	Preferred Shares, Amount [Member]	Common Shares [Member]	Common Shares, Amount [Member]	AOCI [Member]	Accumulated Deficit [Member]
Common Shares, Outstanding				2,219,141
Preferred Shares, Outstanding at Dec. 31, 2018		0
Preferred Shares, Value, Issued at Dec. 31, 2018			$ 0
Total Shareholders' Equity (Deficit) at Dec. 31, 2018	$ (5,607)				$ 183,524	$ (1,816)	$ (187,315)
Shares Issued During Period, Shares, Share-based Compensation, Gross				38,930
Restricted Shares, Value, Shares Issued Net of Tax Withholdings	0				0
Shares Issued During Period, Shares, Issued for Services				42,000
Shares Issued During Period, Value, Issued for Services	105				105
Share-based Compensation	124				124
Other Comprehensive Income (Loss), Net of Tax	40					40
Net Loss	(1,844)						(1,844)
Preferred Shares, Outstanding at Mar. 31, 2019		0
Preferred Shares, Value, Issued at Mar. 31, 2019			0
Total Shareholders' Equity (Deficit) at Mar. 31, 2019	(7,182)				183,753	(1,776)	(189,159)
Preferred Shares, Outstanding at Dec. 31, 2018		0
Preferred Shares, Value, Issued at Dec. 31, 2018			0
Total Shareholders' Equity (Deficit) at Dec. 31, 2018	(5,607)				183,524	(1,816)	(187,315)
Other Comprehensive Income (Loss), Net of Tax	34
Net Loss	(2,624)
Preferred Shares, Outstanding at Sep. 30, 2019		5,843,778
Preferred Shares, Value, Issued at Sep. 30, 2019			5,844
Total Shareholders' Equity (Deficit) at Sep. 30, 2019	(760)				185,117	(1,782)	(189,939)
Common Shares, Outstanding				2,300,071
Preferred Shares, Outstanding at Mar. 31, 2019		0
Preferred Shares, Value, Issued at Mar. 31, 2019			0
Total Shareholders' Equity (Deficit) at Mar. 31, 2019	(7,182)				183,753	(1,776)	(189,159)
Shares Issued During Period, Shares, Share-based Compensation, Gross				3,017
Restricted Shares, Value, Shares Issued Net of Tax Withholdings	0				0
Share-based Compensation	117				117
Other Comprehensive Income (Loss), Net of Tax	2					2
Net Loss	(1,665)						(1,665)
Preferred Shares, Outstanding at Jun. 30, 2019		0
Preferred Shares, Value, Issued at Jun. 30, 2019			0
Total Shareholders' Equity (Deficit) at Jun. 30, 2019	(8,728)				183,870	(1,774)	(190,824)
Common Shares, Outstanding				2,303,088
Preferred Shares, Shares Issued		5,843,778
Preferred shares issued, amount			5,844
Stock Issued During Period, Shares, New Issues				240,000
Stock Issued During Period, Value, New Issues	480				480
Stock Issued During Period, Shares, Other				410,158
Stock Issued During Period, Value, Other	529				529
Shares Issued During Period, Shares, Share-based Compensation, Gross				10,545
Restricted Shares, Value, Shares Issued Net of Tax Withholdings	0				0
Share-based Compensation	238				238
Other Comprehensive Income (Loss), Net of Tax	(8)					(8)
Net Loss	885						885
Preferred Shares, Outstanding at Sep. 30, 2019		5,843,778
Preferred Shares, Value, Issued at Sep. 30, 2019			5,844
Total Shareholders' Equity (Deficit) at Sep. 30, 2019	$ (760)				185,117	(1,782)	(189,939)
Common Shares, Outstanding				2,963,791
Common Shares, Outstanding	3,850,105			3,850,105
Preferred Shares, Outstanding at Dec. 31, 2019	8,443,778	8,443,778
Preferred Shares, Value, Issued at Dec. 31, 2019			8,444
Total Shareholders' Equity (Deficit) at Dec. 31, 2019	$ 1,240				186,161	(1,769)	(191,596)
Shares Issued During Period, Shares, Share-based Compensation, Gross				20,420
Restricted Shares, Value, Shares Issued Net of Tax Withholdings	0				0
Shares Issued During Period, Shares, Issued for Services				146,300
Shares Issued During Period, Value, Issued for Services	130				130
Share-based Compensation	5				5
Other Comprehensive Income (Loss), Net of Tax	(71)					(71)
Net Loss	(1,103)						(1,103)
Preferred Shares, Outstanding at Mar. 31, 2020		8,443,778
Preferred Shares, Value, Issued at Mar. 31, 2020			8,444
Total Shareholders' Equity (Deficit) at Mar. 31, 2020	$ 201				186,296	(1,840)	(192,699)
Preferred Shares, Outstanding at Dec. 31, 2019	8,443,778	8,443,778
Preferred Shares, Value, Issued at Dec. 31, 2019			8,444
Total Shareholders' Equity (Deficit) at Dec. 31, 2019	$ 1,240				186,161	(1,769)	(191,596)
Other Comprehensive Income (Loss), Net of Tax	(31)
Net Loss	$ (4,239)
Preferred Shares, Outstanding at Sep. 30, 2020	9,355,778
Preferred Shares, Value, Issued at Sep. 30, 2020			11,769
Total Shareholders' Equity (Deficit) at Sep. 30, 2020	$ 6,032				191,898	(1,800)	(195,835)
Common Shares, Outstanding				4,016,825
Preferred Shares, Outstanding at Mar. 31, 2020		8,443,778
Preferred Shares, Value, Issued at Mar. 31, 2020			8,444
Preferred shares, Series D, shares		1,244,000
Preferred shares issued, amount	808		808
Convertible Preferred Stock, Shares Issued upon Conversion				450,000
Conversion of preferred shares	292				292
Issuance of common shares for conversion of convertible debt				580,580
Issuance of common shares for conversion of convertible debt, amount	377				377
Total Shareholders' Equity (Deficit) at Mar. 31, 2020	201				186,296	(1,840)	(192,699)
Shares Issued During Period, Shares, Issued for Services				480,000
Shares Issued During Period, Value, Issued for Services	1,194				1,194
Issuance of stock options, settlement of liabilities	54				54
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				30,000
Stock Issued During Period, Value, Stock Options Exercised	75				75
Other Comprehensive Income (Loss), Net of Tax	28					28
Net Loss	(1,946)						(1,946)
Preferred Shares, Outstanding at Jun. 30, 2020		9,687,778
Preferred Shares, Value, Issued at Jun. 30, 2020			9,252
Total Shareholders' Equity (Deficit) at Jun. 30, 2020	1,083				188,288	(1,812)	(194,645)
Common Shares, Outstanding				5,557,405
Preferred Shares, Shares Issued		3,000
Preferred shares issued, amount			2,735
Stock Issued During Period, Shares, New Issues				260,000
Stock Issued During Period, Value, New Issues	268				268
Convertible Preferred Stock, Shares Issued upon Conversion				335,000
Conversion of preferred shares	0				218
Stock Issued During Period, Shares, Purchase of Assets				480,000
Stock Issued During Period, Value, Purchase of Assets	1,560				1,560
Issuance of common shares for conversion of convertible debt				625,240
Issuance of common shares for conversion of convertible debt, amount	406				406
Preferred stock converted to common stock value			(218)
Preferred stock converted to common stock		(335,000)
Shares Issued During Period, Shares, Issued for Services				339,541
Shares Issued During Period, Value, Issued for Services	1,157				1,157
Stock Issued During Period, Value, Stock Options Exercised	1				1
Other Comprehensive Income (Loss), Net of Tax	12					12
Net Loss	$ (1,190)						(1,190)
Preferred Shares, Outstanding at Sep. 30, 2020	9,355,778
Preferred Shares, Value, Issued at Sep. 30, 2020			$ 11,769
Total Shareholders' Equity (Deficit) at Sep. 30, 2020	$ 6,032				$ 191,898	$ (1,800)	$ (195,835)
Common Shares, Outstanding	7,597,186			7,597,186

Organization and Business

Organization and Business	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Organization and Business Sphere 3D Corp. (the “Company”) was incorporated under the Business Corporations Act (Ontario) on May 2, 2007 as T.B. Mining Ventures Inc. On March 24, 2015, the Company completed a short-form amalgamation with a wholly-owned subsidiary. In connection with the short-form amalgamation, the Company changed its name to “Sphere 3D Corp.” The Company delivers data management and desktop and application virtualization solutions through hybrid cloud, cloud and on premise implementations by its global reseller network. The Company achieves this through a combination of containerized applications, virtual desktops, virtual storage and physical hyper-converged platforms. The Company’s products allow organizations to deploy a combination of public, private or hybrid cloud strategies while backing them up with the latest storage solutions. The Company has a portfolio of brands including SnapCLOUD ® , SnapServer ® , SnapSync ® , HVE, and V3 ® . Management has projected that cash on hand and other sources of liquidity may not be sufficient to allow the Company to continue operations beyond December 31, 2020 if we are unable to raise additional funding for operations. We expect our working capital needs to increase in the future as we continue to expand and enhance our operations. Our ability to raise additional funds through equity or debt financings or other sources may depend on the financial success of our current business and successful implementation of our key strategic initiatives, financial, economic and market conditions and other factors, some of which are beyond our control. No assurance can be given that we will be successful in raising the required capital at reasonable cost and at the required times, or at all. Further equity financings may have a dilutive effect on shareholders and any debt financing, if available, may require restrictions to be placed on our future financing and operating activities. If we require additional capital and are unsuccessful in raising that capital, we may not be able to continue our business operations and advance our growth initiatives, which could adversely impact our business, financial condition and results of operations. Significant changes from the Company’s current forecasts, including but not limited to: (i) failure to comply with the terms and financial covenants in its debt facilities; (ii) shortfalls from projected sales levels; (iii) unexpected increases in product costs; (iv) increases in operating costs; (v) changes in the historical timing of collecting accounts receivable; and (vi) inability to maintain compliance with the requirements of the NASDAQ Capital Market and/or inability to maintain listing with the NASDAQ Capital Market could have a material adverse impact on the Company’s ability to access the level of funding necessary to continue its operations at current levels. If any of these events occurs or the Company is unable to generate sufficient cash from operations or financing sources, the Company may be forced to liquidate assets where possible and/or curtail, suspend or cease planned programs or operations generally or seek bankruptcy protection or be subject to an involuntary bankruptcy petition, any of, which would have a material adverse effect on the Company’s business, results of operations, financial position and liquidity. The Company incurred losses from operations and negative cash flows from operating activities for the nine months ended September 30, 2020, and such losses may continue for the foreseeable future. Based upon the Company's current expectations and projections for the next year, the Company believes that it may not have sufficient liquidity necessary to sustain operations beyond December 31, 2020. These factors, among others, raise substantial doubt that the Company will be able to continue as a going concern. The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Merger Agreement On July 14, 2020, the Company entered into a definitive merger agreement (the “Rainmaker Merger Agreement”) pursuant to which it will acquire all of the outstanding securities of Rainmaker Worldwide Inc. (“Rainmaker”), a global Water-as-a-Service (“WaaS”) provider. Upon closing, the Company’s name will change to Rainmaker Worldwide Inc., and its business model will focus on Water-as-a-Service. Rainmaker management will assume leadership of the combined entity. Under the terms of the agreement, Rainmaker, a Nevada company, will merge with S3D Nevada Inc., a Nevada company wholly-owned by the Company, and the merged entity will be a wholly-owned subsidiary of the Company. Upon completion of the transaction the Company expects to remain listed on the NASDAQ market and will change its name to Rainmaker Worldwide Inc. After completion of the transaction, it is expected that current holders of Rainmaker will own a minority stake of the Company, on a fully diluted basis, as a result of their exchange of securities in the transaction. The transaction is subject to completion of an equity financing, or series of financings, for a minimum of $15.0 million at a share price to be mutually agreed upon prior to closing and such other customary regulatory and shareholder approvals, including the approval of NASDAQ. Closing is expected to occur prior to December 31, 2020 and subject to extension to February 28, 2021 in certain circumstances. The intent of the transaction is to transform the Company to a Commercial WaaS provider. On September 14, 2020, the parties to the Merger Agreement entered into Amendment No. 1 to Agreement and Plan of Merger (the “Rainmaker Amendment”). Under the Rainmaker Amendment, the ratio of the Company’s common shares to be received by Rainmaker shareholders has changed from one-third of a common share of the Company per common or preferred share of Rainmaker to 1/15 of a share. On September 14, 2020, the Company entered into a Senior Secured Convertible Promissory Note with Rainmaker (the “Rainmaker Note”), pursuant to which the Company loaned Rainmaker the principal amount of $3.1 million comprised of: (a) a new advance of $1.85 million paid to Rainmaker on October 1, 2020, (b) the principal and any interest owing under existing promissory notes issued by Rainmaker to two investors on April 2, 2020 in the aggregate amount of $1.1 million, which indebtedness was assigned to the Company on May 4, 2020 (the “Assigned Notes”), and (c) a promissory note in the principal amount of $150,000 issued to the Company on August 4, 2020 (the “Original Note”). The Assigned Notes and the Original Note are included in the principal amount of the Rainmaker Note and therefore, the Assigned Notes and the Original Notes are deemed cancelled. The Rainmaker Note shall be secured as a registered lien under the Uniform Commercial Code and the Personal Property Security Act (Ontario) against the assets of Rainmaker and shall bear interest at the rate of 10% per annum. The principal and interest shall accrue monthly and be due and payable in full on September 14, 2023.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Significant Accounting Policies Principles of Consolidation The condensed consolidated financial statements of the Company have been prepared by management in accordance with accounting principles generally accepted in the United States of America (“GAAP”), applied on a basis consistent for all periods. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for a complete set of financial statements. These condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on May 13, 2020. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. These condensed consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany balances and transactions have been appropriately eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Significant areas requiring the use of management estimates relate to the determination of provisions for impairment assessments of goodwill, other indefinite-lived intangible assets; revenue; allowance for doubtful receivables; inventory valuation; warranty provisions; and litigation claims. Actual results could differ from these estimates. Foreign Currency Translation The financial statements of foreign subsidiaries, for which the functional currency is the local currency, are translated into U.S. dollars using the exchange rate at the consolidated balance sheet date for assets and liabilities and a weighted-average exchange rate during the year for revenue, expenses, gains and losses. Translation adjustments are recorded as other comprehensive income (loss) within shareholders’ equity. Gains or losses from foreign currency transactions are recognized in the condensed consolidated statements of operations. Such transactions resulted in a loss of $8,000 and $5,000 in the three months ended September 30, 2020 and 2019, respectively, and a loss of $9,000 and $13,000 in the nine months ended September 30, 2020 and 2019, respectively. Cash Equivalents Highly liquid investments with insignificant interest rate risk and original maturities of three months or less, when purchased, are classified as cash equivalents. Cash equivalents are composed of money market funds. The carrying amounts approximate fair value due to the short maturities of these instruments. Accounts Receivable Accounts receivable is recorded at the invoiced amount and is non-interest bearing. We estimate our allowance for doubtful accounts based on an assessment of the collectability of specific accounts and the overall condition of the accounts receivable portfolio. When evaluating the adequacy of the allowance for doubtful accounts, we analyze specific trade and other receivables, historical bad debts, customer credits, customer concentrations, customer credit-worthiness, current economic trends and changes in customers’ payment terms and/or patterns. We review the allowance for doubtful accounts on a quarterly basis and record adjustments as considered necessary. Customer accounts are written-off against the allowance for doubtful accounts when an account is considered uncollectable. Inventories Inventories are stated at the lower of cost and net realizable value using the first-in-first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We assess the value of inventories periodically based upon numerous factors including, among others, expected product or material demand, current market conditions, technological obsolescence, current cost, and net realizable value. If necessary, we write down our inventory for obsolete or unmarketable inventory by an amount equal to the difference between the cost of the inventory and the net realizable value. Investment in Affiliate The Company holds an investment in equity securities of a nonpublic company for business and strategic purposes. The equity securities do not have a readily determinable fair value and are carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company reviews its investment on a regular basis to determine if the investment is impaired. For purposes of this assessment, the Company considers the investee’s cash position, earnings and revenue outlook, liquidity and management ownership, among other factors, in its review. If management’s assessment indicates that an impairment exists, the Company estimates the fair value of the equity investment and recognizes in current earnings an impairment loss that is equal to the difference between the fair value of the equity investment and its carrying amount. Goodwill and Intangible Assets Goodwill represents the excess of consideration paid over the value assigned to the net tangible and identifiable intangible assets acquired. For intangible assets purchased in a business combination, the estimated fair values of the assets received are used to establish their recorded values. For intangible assets acquired in a non-monetary exchange, the estimated fair values of the assets transferred (or the estimated fair values of the assets received, if more clearly evident) are used to establish their recorded values. Valuation techniques consistent with the market approach, income approach and/or cost approach are used to measure fair value. Purchased intangible assets are amortized on a straight-line basis over their economic lives of 15 years for supplier agreement, six to 25 years for channel partner relationships, three to nine years for developed technology, three to eight years for capitalized development costs, and two to 25 years for customer relationships as this method most closely reflects the pattern in which the economic benefits of the assets will be consumed. Impairment of Goodwill and Intangible Assets Goodwill and intangible assets are tested for impairment on an annual basis at December 31, or more frequently if there are indicators of impairment. Triggering events for impairment reviews may be indicators such as adverse industry or economic trends, restructuring actions, lower projections of profitability, or a sustained decline in our market capitalization. Intangible assets are quantitatively assessed for impairment, if necessary, by comparing their estimated fair values to their carrying values. If the carrying value exceeds the fair value, the difference is recorded as an impairment. Revenue Recognition The Company accounts for revenue pursuant to ASU 2014-09, Revenue from Contracts with Customers and all the related amendments (“Topic 606”). Under Topic 606, an entity is required to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, and contract consideration will be recognized on a “sell-in basis” or when control of the purchased goods or services transfer to the distributor. The Company generates revenue primarily from: (i) solutions for standalone storage and integrated hyper-converged storage; (ii) professional services; and (iii) warranty and customer services. The Company recognizes revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the promised goods or services in the contract; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. Approximately 70% of the Company’s revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied at a point in time. These contracts are generally comprised of a single performance obligation to transfer products. Accordingly, the Company recognizes revenue when change of control has been transferred to the customer, generally at the time of shipment of products. The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically less than 45 days. Revenue on direct product sales, excluding sales to distributors, are not entitled to any specific right of return or price protection, except for any defective product that may be returned under our standard product warranty. Product sales to distribution customers that are subject to certain rights of return, stock rotation privileges and price protections, contain a component of “variable consideration.” Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products and is generally based upon a negotiated fixed price and is net of estimates for variable considerations. For performance obligations related to warranty and customer services, such as extended product warranties, the Company transfers control and recognizes revenue on a time-elapsed basis. The performance obligations are satisfied as services are rendered typically on a stand-ready basis over the contract term, which is generally 12 months. In limited circumstances where a customer is unable to accept shipment and requests products be delivered to, and stored on, the Company’s premises, also known as a “bill-and-hold” arrangement, revenue is recognized when: (i) the customer has requested delayed delivery and storage of the products, (ii) the goods are segregated from the inventory, (iii) the product is complete, ready for shipment and physical transfer to the customer, and (iv) the Company does not have the ability to use the product or direct it to another customer. The Company also enters into revenue arrangements that may consist of multiple performance obligations of its product and service offerings such as for sales of hardware devices and extended warranty services. The Company allocates contract fees to the performance obligations on a relative stand-alone selling price basis. The Company determines the stand-alone selling price based on its normal pricing and discounting practices for the specific product and/or service when sold separately. When the Company is unable to establish the individual stand-alone price for all elements in an arrangement by reference to sold separately instances, the Company may estimate the stand-alone selling price of each performance obligation using a cost plus a margin approach, by reference to third party evidence of selling price, based on the Company’s actual historical selling prices of similar items, or based on a combination of the aforementioned methodologies; whichever management believes provides the most reliable estimate of stand-alone selling price. Warranty and Extended Warranty The Company records a provision for standard warranties provided with all products. If future actual costs to repair were to differ significantly from estimates, the impact of these unforeseen costs or cost reductions would be recorded in subsequent periods. Separately priced extended on-site warranties and service contracts are offered for sale to customers on all product lines. The Company contracts with third party service providers to provide service relating to on-site warranties and service contracts. Extended warranty and service contract revenue and amounts paid in advance to outside service organizations are deferred and recognized as service revenue and cost of service, respectively, over the period of the service agreement. The Company will typically apply the practical expedient to agreements wherein the period between transfer of any good or service in the contract and when the customer pays for that good or service is one year or less. Advanced payments for long-term maintenance and warranty contracts do not give rise to a significant financing component. Rather, such payments are required by the Company primarily for reasons other than the provision of finance to the entity. Research and Development Costs Research and development expenses include payroll, employee benefits, share-based compensation expense, and other headcount-related expenses associated with product development. Research and development expenses also include third-party development and programming costs. Comprehensive Income (Loss) Comprehensive income (loss) and its components encompass all changes in equity other than those arising from transactions with shareholders, including net loss and foreign currency translation adjustments, and is disclosed in a separate condensed consolidated statement of comprehensive loss. Share-based Compensation We account for share-based awards, and similar equity instruments, granted to employees, non-employee directors, and consultants under the fair value method. Share-based compensation award types include stock options and restricted stock. We use the Black-Scholes option pricing model to estimate the fair value of option awards on the measurement date, which generally is the date of grant. The expense is recognized over the requisite service period (usually the vesting period) for the estimated number of instruments for which service is expected to be rendered. The fair value of restricted stock units (“RSUs”) is estimated based on the market value of the Company’s common shares on the date of grant. The fair value of options granted to non-employees is estimated at the measurement date using the Black-Scholes option pricing model. Share-based compensation expense for options with graded vesting is recognized pursuant to an accelerated method. Share-based compensation expense for RSUs is recognized over the vesting period using the straight-line method. Share-based compensation expense for an award with performance conditions is recognized when the achievement of such performance conditions are determined to be probable. If the outcome of such performance condition is not determined to be probable or is not met, no compensation expense is recognized and any previously recognized compensation expense is reversed. Forfeitures are recognized in share-based compensation expense as they occur. We have not recognized, and do not expect to recognize in the near future, any tax benefit related to share-based compensation cost as a result of the full valuation allowance of our net deferred tax assets and its net operating loss carryforward. Recently Issued Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) that are adopted by the Company as of the specified effective date. If not discussed, the Company believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s consolidated financial statements upon adoption. Recently Adopted Accounting Pronouncements In August 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-13, Fair Value Measurement (Topic 820) (“ASU 2018-13”) . The new guidance removes, modifies and adds to certain disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement. The update is effective for annual reporting periods, including interim periods, beginning after December 15, 2019. The adoption of the new standard did not have an effect on our financial position, results of operations or cash flows. In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350) - Simplifying the Test for Goodwill Impairment (“ASU 2017-04”) . The update simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. An entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, if applicable. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The same impairment test also applies to any reporting unit with a zero or negative carrying amount. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The update is effective for annual reporting periods, including interim periods, beginning after December 15, 2019, on a prospective basis. The adoption of the new standard did not have an effect on our financial position, results of operations or cash flows.

Certain Balance Sheet Items

Certain Balance Sheet Items	9 Months Ended
	Sep. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Inventories Disclosures [Text Block]	The following table summarizes inventories (in thousands): September 30, December 31, Raw materials $ 120 $ 92 Work in process 166 137 Finished goods 373 524 $ 659 $ 753 The following table summarizes other current assets (in thousands): September 30, December 31, Prepaid services $ 632 $ 23 Prepaid insurance 169 184 Transition service agreement 78 345 Deferred cost - service contracts 108 118 Other 11 — $ 998 $ 670 The following table summarizes other assets (in thousands): September 30, December 31, Convertible promissory note receivable long-term $ 3,128 $ — Prepaid insurance and services 418 519 Deferred cost – service contracts 75 154 Other 15 6 $ 3,636 $ 679

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	Intangible Assets The following table summarizes intangible assets, net (in thousands): September 30, December 31, Developed technology $ 13,323 $ 13,323 Supplier agreement 1,560 — Channel partner relationships 730 730 Capitalized development costs (1) 2,959 3,047 Customer relationships 380 380 18,952 17,480 Accumulated amortization: Developed technology (13,038) (12,682) Supplier agreement (17) — Channel partner relationships (446) (355) Capitalized development costs (1) (2,303) (2,094) Customer relationships (337) (328) (16,141) (15,459) Total finite-lived assets, net 2,811 2,021 Indefinite-lived intangible assets - trade names 280 280 Total intangible assets, net $ 3,091 $ 2,301 ________________ (1) Includes the impact of foreign currency exchange rate fluctuations. Amortization expense of intangible assets was $258,000 and $252,000 during the three months ended September 30, 2020 and 2019, respectively. Amortization expense of intangible assets was $740,000 and $771,000 during the nine months ended September 30, 2020 and 2019, respectively. Estimated amortization expense for intangible assets is expected to be approximately $228,000 for the remainder of 2020 and $606,000, $459,000, $138,000, $116,000, and $115,000 in fiscal 2021, 2022, 2023, 2024 and 2025, respectively.

Investment in Affiliate (Notes)

Investment in Affiliate (Notes)	9 Months Ended
	Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Investments in and Advances to Affiliates, Schedule of Investments [Text Block]	Investment in Affiliate In November 2018, in connection with the divestiture of Overland, the Company received 1,879,699 Silicon Valley Technology Partners (“SVTP”) Preferred Shares representing 19.9% of the outstanding shares of capital stock of SVTP with a fair value of $2.1 million. The fair value of this investment was estimated using discounted cash flows and consideration of the Exchange Agreement described below. The Company concluded it does not have a significant influence over the investee. There were no known identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment at September 30, 2020. In November 2018, the Company also entered into an Exchange and Buy-Out Agreement (the “Exchange Agreement”), between the Company, FBC Holdings, SVTP, and MF Ventures LLC (“MFV”). Under the terms of the Exchange Agreement, (i) the Company granted FBC Holdings the right to exchange up to 2,500,000 of the Company’s Series B Preferred Shares held by FBC Holdings for up to all of the SVTP Preferred Shares held by the Company (the “Exchange Right”), with such Exchange Right expiring within two years of the November 2018 closing. On July 12, 2019, in connection with the Exchange Agreement, the Company entered into an amendment to the Exchange Agreement by and among the Company, FBC Holdings, SVTP and MFV such that the rights and obligations under the Exchange Agreement would apply to the Series B Preferred Shares in respect of which the Series A Preferred Shares were exchanged under the Share Exchange Agreement.

Debt

Debt	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Debt On August 27, 2020, the Company entered into a settlement agreement with O’Melveny & Myers LLP (“OMM”) pursuant to which the Company issued to OMM a secured promissory note (the “OMM Note”) in the aggregate principal amount of $1.1 million in satisfaction of certain accounts payable owed to OMM. The OMM Note bears interest at 1.68% per annum and matures on December 30, 2020. The Company may prepay any amounts outstanding under the OMM Note at any time. The Company’s obligations pursuant to the OMM Note are secured by substantially all of the Company’s assets. The Company recorded a gain on forgiveness of liabilities in the amount of $600,000 which is included in other income. On July 28, 2020, the Company entered into a Securities Purchase Agreement with Oasis Capital (“Oasis”), a related party of the Company, pursuant to which the Company received $500,000 and issued to Oasis (i) an 8.0% original issue discount promissory note payable, with a six On April 9, 2020, the Company received loan proceeds in the amount of $667,400 (the “PPP Funds”) and entered into a loan agreement with Citizens National Bank of Texas pursuant to the CARES Act. The CARES Act was established in order to enable small businesses to pay employees during the economic slowdown caused by COVID-19 by providing forgivable loans to qualifying businesses for up to 2.5 times their average monthly payroll costs. The amount borrowed by the Company under the CARES Act is eligible to be forgiven provided that (a) the Company uses the PPP Funds during the eight week period after receipt thereof, and (b) the PPP Funds are only used to cover payroll costs (including benefits), rent, mortgage interest, and utility costs. The amount of loan forgiveness will be reduced if, among other reasons, the Company does not maintain staffing or payroll levels. Principal and interest payments on any unforgiven portion of the PPP Funds (the “PPP Loan”) will be deferred for six months and will accrue interest at a fixed annual rate of 1.0% and carry a two Convertible Debt and Warrants On February 13, 2020, the Company entered into a business advisory agreement with Torrington Financial Services Ltd (“Torrington”), a financial adviser to the Company. As a result of the March 23, 2020 transaction, Torrington and its entity under common control, Lallande Poydras Investment Partnership (“Lallande”), both participated in the below offering and are classified as a related party of the Company. On March 23, 2020, the Company entered into subscription agreements by and among the Company and the investors party thereto, including Torrington and Lallande, for the purchase and sale of 725 units (collectively, the “Units” and individually, a “Unit”) for aggregate gross proceeds of $725,000 with each Unit consisting of (a) a 6.0% convertible debenture in the principal amount of $1,000, which is convertible at $0.6495 per share into 1,540 common shares of the Company, and (b) a warrant to purchase 1,540 common shares of the Company exercisable at any time on or before the third year anniversary date at an exercise price of $0.60 per share. The warrant includes a provision restricting the warrant holder from exercising it if the aggregate number of common shares held by the warrant holder equals or exceeds 5.0% of the issued and outstanding shares of the Company, calculated on a partially converted basis (i.e., assuming the conversion of all rights to receive common shares of the Company held by the warrant holder). All values are assigned to the debts and no value has been assigned to the equity component. Torrington and Lallande participated in the offering and in the aggregate purchased 200 units, as well as for compensation for Torrington’s services, the Company issued to Torrington convertible debentures equal to $58,000 and convertible into 89,320 common shares and a warrant for the purchase of 89,320 shares, with other terms substantially the same as the investors. The Company received cash proceeds of $575,000 from the offering, and a participant of the offering paid on the Company’s behalf $150,000 directly to a business advisor for a prepayment of future services to the Company. The Company intends to use the remaining proceeds from the offering for general corporate and working capital purposes. During the nine months ended September 30, 2020, the Company converted $783,000 of convertible debt, including Torrington’s fee and issued 1,206,545 common shares of the Company, of which $408,000 of debt converted was held by related parties, and they were issued in the aggregate 628,320 common shares. During the nine months ended September 30, 2020, the Company issued 200,000 common shares of the Company for the exercise of the March 23, 2020 warrants and received $120,000 in proceeds. Line of credit The Company has a line of credit agreement with a bank with a maximum borrowing limit, effective July 2, 2019, of $500,000. Borrowings under this agreement bear interest at a rate of 6.5% per annum. The line of credit expires on December 31, 2020. Borrowings under the line of credit are secured by the inventory and accounts receivable balances of the Company. At September 30, 2020, the outstanding balance was $489,000. The line of credit agreement also contains customary insurance requirements, limits on cross collateralization and events of default, including, among other things, failure to make payments, insolvency or bankruptcy, business termination, merger or consolidation or acquisition without written consent, a material impairment in the perfection or priority of the Lender’s lien in the collateral or in the value of such collateral, or material adverse change to the business that would impair the loan.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	Fair Value Measurements The authoritative guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Assets and Liabilities that are Measured at Fair Value on a Recurring Basis Our financial instruments include cash equivalents, accounts receivable, accounts payable, accrued expenses, debt, related party debt and preferred shares. Fair value estimates of these instruments are made at a specific point in time, based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, note receivable, prepaid expenses, accounts payable and accrued expenses are generally considered to be representative of their respective fair values because of the short-term nature of those instruments. The carrying value of debt and related party debt approximates its fair value as the borrowing rates are substantially comparable to rates available for loans with similar terms. The Company estimates the fair value of the preferred shares utilizing Level 2 inputs, including market yields for similar instruments. Assets and Liabilities that are Measured at Fair Value on a Nonrecurring Basis The Company's non-financial assets such as investment in affiliate, goodwill, intangible assets and property and equipment are recorded at fair value when an impairment is recognized or at the time acquired in a business combination.

Preferred Shares (Notes)

Preferred Shares (Notes)	9 Months Ended
	Sep. 30, 2020
Class of Stock Disclosures [Abstract]
Preferred Stock [Text Block]	Preferred Shares Series E Preferred Shares On September 17, 2020, the Company filed articles of amendment to create a fifth series of preferred shares, being, an unlimited number of Series E Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto. Each Series E Preferred Share shall have a stated value of $1,000 and is convertible into the Company’s common shares at a conversion price equal to the lower of (i) 80% of the average of the three lowest VWAPs of the common stock during the ten trading days immediately preceding, but not including, the conversion date and (ii) $2.00; however, in no event shall the conversion price be lower than $1.00 per share. The Series E Preferred Shares are non-voting and pay dividends at a rate of 8.0% per annum, payable quarterly. The shareholder of the Series E Preferred Shares, may, at any time, convert all or any Series E Preferred Shares provided that (i) the common shares issuable upon such conversion, together with all other common shares of the Company held by the shareholder in the aggregate, would not cause such shareholder’s ownership of the Company’s common shares to exceed 9.99% of the total number of outstanding common shares of the Company (ii) and such conversion would not exceed the maximum number of Sphere common shares that may be issued upon conversion of all shares of Series E Preferred Stock in the aggregate of 1,500,000 common shares. On September 14, 2020, the Company entered into a Securities Purchase Agreement with an investor relating to the issuance and sale to the investor of 3,000 shares of the Company’s subsequently established Series E Convertible Preferred Shares in a private placement transaction for net proceeds of $2.7 million. On September 23, 2020, the Company entered into an amendment to the Securities Purchase Agreement. Under the amendment, the investor and the Company agreed that to the extent the investor converts any Series E Preferred Shares into common shares, such common shares shall be prohibited from being voted with respect to any proposal related to the transactions contemplated by the Securities Purchase Agreement, including any proposal seeking to obtain shareholder approval of the transactions contemplated by the Securities Purchase Agreement in accordance with Nasdaq rules. The Company paid a related party, Torrington, a business advisory fee of $240,000 related to this transaction. Series D Preferred Shares On May 6, 2020, the Company filed articles of amendment to create a fourth series of preferred shares, being, an unlimited number of Series D Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto. The Series D Preferred Shares are convertible into our common shares, at a conversion price equal to $0.65, subject to certain anti-dilution adjustments. Each shareholder of the Series D Preferred Shares, may, at any time, convert all or any part of the Series D Preferred Shares provided that after such conversion the common shares issuable, together with all the common shares held by the shareholder in the aggregate would not exceed 9.9% of the total number of outstanding common shares of the Company or in the aggregate no more than the exchange cap of 800,000 common shares by all holders of Series D Preferred Shares. On April 30, 2020, the Company entered into a Securities Purchase Agreement with two investors (the “Purchasers“) relating to the issuance and sale, in the aggregate, of 1,694,000 shares (the “Shares“) of the Company's subsequently established Series D Convertible Preferred Shares, no par value and warrants to purchase up to 1,694,000 common shares of the Company in a private placement transaction, in exchange for the assignment to the Company by the investors of certain convertible promissory notes receivable held by the investors in an aggregate amount of $1.1 million. Subject to certain limitations, the warrants will be exercisable commencing on the six month anniversary at an exercise price equal to $0.92 per common share, subject to adjustments as provided under the terms of the warrants, and are exercisable for a five During the nine months ended September 30, 2020, the Company converted 785,000 shares of the Series D Preferred Shares and issued 785,000 common shares of the Company. As a result of the conversion, one of the Purchasers, Gora Consulting Corp. (“Gora”) is classified as a related party of the Company. Gora participated in the Securities Purchase Agreement by acquiring 847,000 Shares and warrants to purchase 847,000 common shares, in exchange for the assignment to the Company certain promissory notes receivable held by Gora in an aggregate amount of $550,000. During the nine months ended September 30, 2020, Gora converted 485,000 Series D Preferred Shares and was issued 485,000 common shares of the Company. In addition, on April 21, 2020, the sole owner of Gora entered into a share purchase agreement with an employee of the Company and acquired 211,745 common shares of the Company. Series C Preferred Shares On October 30, 2019, the directors of the Company passed a resolution authorizing the filing of articles of amendment to create a third series of preferred shares, being, an unlimited number of Series C Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto. On November 6, 2019, the Company filed the Articles of Amendment to create the Series C Preferred Shares. Pursuant to the articles of amendment governing the rights and preferences of outstanding shares of Series C Preferred Shares, each preferred share, subject to prior shareholder approval, are convertible into our common shares, at a conversion rate in effect on the date of conversion. Overland, a related party and the sole shareholder of the Series C Preferred Shares, agreed that it would not exercise its conversion right with respect to its Series C Preferred Shares until the earlier of (i) October 31, 2020 and (ii) such time that we file for bankruptcy or an involuntary petition for bankruptcy is filed against us (unless such petition is dismissed or discharged within 30 days) provided that after such conversion the common shares issuable, together with the aggregate common shares held by Overland would not exceed 19.9% of the total number of outstanding common shares of the Company. At September 30, 2020, the Company has issued and outstanding 1,600,000 Series C Preferred Shares of the Company valued at $1.00 per share. Series B Preferred Shares In July 2019, the Company filed articles of amendment to create a second series of preferred shares, being, an unlimited number of Series B Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto. In July 2019, following the filing of the Articles of Amendment to create the Series B Preferred Shares, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with FBC Holdings to exchange 6,500,000 Series A Preferred Shares held by FBC Holdings for 6,500,000 Series B Preferred Shares. On July 14, 2020, the Company entered into a lock-up agreement (the "Lock-up Agreement") with FBC Holdings with respect to the 6,500,000 Series B Preferred Shares of the Company owned by FBC. Pursuant to the terms of the Lock-up Agreement, FBC has agreed that for the period of time between (a) July 14, 2020 and (b) the earlier to occur of (i) April 30, 2021 and (ii) the date that is 180 days after a Change of Control (as defined in the Lock-up Agreement), it will not without the prior written consent of the Company convert any of the Series B Preferred Shares into common shares of the Company. In July 2019, in connection with the Share Exchange Agreement, the Company entered into an amendment to the Exchange and Buy-Out Agreement by and among the Company, FBC Holdings, SVTP and MFV such that the rights and obligations under the Exchange and Buy-Out Agreement would apply to the Series B Preferred Shares in respect of which the Series A Preferred Shares were exchanged under the Share Exchange Agreement. In August 2019, the Company issued 343,778 Series B Preferred Shares with a fair value of $343,778 to FBC Holdings in satisfaction of accrued dividends at such date. For the three and nine months ended September 30, 2020, there was no related party interest expense related to preferred shares dividends. For the three and nine months ended September 30, 2019, there was related party interest expense of $30,000 and $291,000, respectively, related to preferred shares dividends. The Series B Preferred Shares (i) are convertible into the Company’s common shares, subject to prior shareholder approval, at a conversion rate equal to $1.00 per share, plus accrued and unpaid dividends, divided by an amount equal to 0.85 multiplied by a 15-day volume weighted average price per common share prior to the date the conversion notice is provided (the “Conversion Rate”), subject to a conversion price floor of $0.80, (ii) if the Company receives any cash dividends on its equity investment in Silicon Valley Technology Partners, Inc., in an amount equal to such cash dividend received, cumulative cash dividends at a rate of 8.0% of the Series B Preferred Shares, (iii) after November 13, 2020, fixed, preferential, cumulative cash dividends at the rate of 8.0% of the Series B Preferred Shares subscription price per year, and (iv) carry a liquidation preference equal to the subscription price per Series B Preferred Share plus any accrued and unpaid dividends. The common shares issuable upon the conversion of the Series B Preferred Shares may constitute more than 20% of the common shares of the Company currently outstanding and may result in a change of control of the Company, and therefore the Company will seek shareholder approval for the issuance of all common shares issuable upon conversion of the Series B Preferred Shares. In the event shareholder approval is not obtained, FBC Holdings and its affiliates will not be entitled to convert such Series B Preferred Shares into common shares, but any unaffiliated transferee may convert all or any part of the Series B Preferred Shares held by such transferee into the number of fully paid and non-assessable common shares that is equal to the number of Series B Preferred Shares to be converted multiplied by the Conversion Rate in effect on the date of conversion; provided that, (x) after such conversion, the common shares issuable upon such conversion, together with all common shares held by such third party transferee that are or would be deemed to be aggregated under the rules of the Nasdaq Stock Market, in the aggregate would not exceed 19.9% of the total number of common shares of the Company then outstanding and (y) such conversion and issuance would not otherwise violate or cause the Company to violate the Company’s obligations under the rules or regulations of the Nasdaq Stock Market. Management has determined that the conversion terms of the Series B Preferred Shares, Series C Preferred Shares, Series D Preferred Shares and Series E Preferred Shares do not cause the preferred shares to be treated as liability instruments, and accordingly such preferred shares are presented as equity instruments.

Share Capital

Share Capital	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Share Capital On June 1, 2020, the Company entered into a consulting agreement with GROUPE PARAMEUS CORP (“GROUPE P”) to provide consulting services for one year to the Company in the area of corporate finance, investor communications and financial and investor public relations. As compensation for GROUPE P’s services to be provided pursuant to the consulting agreement, in addition to a prepayment of $150,000 in cash, the Company granted 100,000 restricted stock awards, 100,000 common shares of the Company pursuant to the terms of Regulation D under the Securities Act of 1933, and a non-qualified stock option for the purchase of 50,000 common shares at an exercise price of $2.52 per share with a vest period over six months. On June 16, 2020, the Company issued 200,000 common shares to GROUPE P with a fair value of $504,000. On April 24, 2020, the Company entered into a consulting agreement with ROK Consulting Inc. (“ROK”) to provide consulting services to the Company in the area of corporate finance, investor communications and financial and investor public relations (the “ROK Consulting Agreement”). As compensation for ROK’s services to be provided pursuant to the ROK Consulting Agreement, in addition to cash compensation, the Company agreed to issue to ROK 375,000 common shares of the Company. On June 19, 2020, the Company issued 150,000 common shares of the Company with a fair value of $360,000 to ROK per the terms of the ROK Consulting Agreement. On August 4, 2020, the Company issued 225,000 common shares of the Company with a fair value of $725,000 to ROK per the terms of the ROK Consulting Agreement. In May 2020, the Company entered into an equity purchase agreement and registration rights agreement with Oasis Capital, LLC (“Oasis Capital”), to purchase from the Company up to $11.0 million worth of common shares of the Company. Under the purchase agreement, the Company has the right to sell up to $11.0 million of its common shares to Oasis Capital over a 36-month period, upon satisfaction of the conditions in the purchase agreement, including the effectiveness of a resale registration statement filed on Form S-1. The Company will control the timing and amount of any sales to Oasis Capital, and Oasis Capital is obligated to make purchases in accordance with the purchase agreement, upon certain terms and conditions being met. The purchase agreement, which contains a floor price of $1.58 per common share, allows the Company to fund its needs in a more expedient and cost-effective manner, on the pricing terms set forth in the purchase agreement. The equity line is designed to provide capital to the company as it is required. During the nine months ended September 30, 2020, the Company issued 60,000 common shares to Oasis Capital for gross proceeds of $140,000 under the terms and conditions of the equity purchase agreement. In October 2020, the Company issued 140,000 common shares to Oasis Capital for gross proceeds of $249,000 under the terms and conditions of the Oasis Capital equity purchase agreement. In October 2019, the Company entered into a share purchase agreement and issued 149,500 common shares of the Company at $1.19 per share to a supplier in exchange for the satisfaction of certain accounts payable. The aggregate amount of the obligations shall be reduced by the cash proceeds actually received by the supplier from the sale of the common shares. On May 26, 2020, the Company received notification of the sale of common shares had been settled and the Company received a reduction to its outstanding accounts payable of $299,000. In October 2019, the Company entered into a share purchase agreement with a related party supplier of the Company and issued 330,000 common shares of the Company at $1.07 per share to the supplier in exchange for the satisfaction of certain accounts payable. The aggregate amount of the obligations shall be reduced by the cash proceeds actually received by the supplier from the sale of the common shares. On April 21, 2020, the Company received notification of the sale of common shares had been settled and the Company received a reduction to its outstanding accounts payable of $153,000. In August 2019, the Company entered into a purchase agreement for a private placement to issue 251,823 common shares of the Company, of which 175,765 common shares have been issued at a purchase price of $1.29 per share for gross proceeds of $325,000. The remaining 76,058 common shares are pending issuance due to the Company not receiving the information necessary to issue the common shares. The Company used the proceeds from the offering for general corporate and working capital purposes. Warrants At September 30, 2020, the Company had the following outstanding warrants to purchase common shares: Date issued Contractual life (years) Exercise price Number outstanding Expiration October 2015 5 $466.00 2,010 October 14, 2020 December 2015 5 $500.00 5,138 December 15, 2020 December 2015 5 $216.00 7,500 December 4, 2020 March 2016 5 $500.00 150 March 4, 2021 August 2017 5 $42.00 37,500 August 11, 2022 August 2017 5 $42.00 11,876 August 16, 2022 August 2017 5 $42.00 25,625 August 22, 2022 April 2018 5 $5.60 111,563 April 17, 2023 March 2020 3 $0.60 1,005,820 March 23, 2023 April 2020 5 $0.92 1,694,000 April 30, 2025 2,901,182 (1) _______________ (1) Includes warrants to purchase up to 2,002,000 common shares, in the aggregate, outstanding to related parties at September 30, 2020.

Equity Incentive Plan

Equity Incentive Plan	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement [Text Block]	Equity Incentive Plans During the nine months ended September 30, 2020 and 2019, the Company granted awards of restricted stock units of none and 100,000, respectively, of which the 100,000 granted in 2019 were outside of the 2015 Performance Incentive Plan. The restricted stock units were recorded at fair value on the date of grant. Restricted stock units typically vest over a period of approximately three years. The restricted stock units granted outside of the 2015 Performance Incentive Plan are fully vested. During the nine months ended September 30, 2020, the Company entered into various consulting agreements for business advisory services and granted to the same business advisors, in the aggregate, non-qualified stock options for the purchase of 130,000 common shares with an exercise price of $2.52 per share in lieu of cash payment for services performed of which 30,000 of such non-qualified options were granted to, and exercised by, a related party. Restricted Stock Awards During the nine months ended September 30, 2020 and 2019, the Company granted restricted stock awards (“RSA”) in lieu of cash payment for services performed. The estimated fair value of the RSAs was based on the market value of the Company’s common shares on the date of grant. During the nine months ended September 30, 2020 and 2019, the Company granted RSAs of 400,841 and 42,000, respectively, with a fair value of $771,000 and $105,000, respectively. Share-Based Compensation Expense The Company recorded the following compensation expense related to its share-based compensation awards: Three Months Nine Months 2020 2019 2020 2019 Cost of sales $ — $ — $ — $ 205 Sales and marketing — 192,446 2,014 271,763 Research and development — 15,705 2,532 52,326 General and administrative — 29,607 — 153,663 Total share-based compensation expense $ — $ 237,758 $ 4,546 $ 477,957 As of September 30, 2020, there was no unrecognized compensation expense related to equity-based compensation awards.

Net (Loss) Income Per Share

Net (Loss) Income Per Share	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Net (Loss) Income per Share Basic net income (loss) per share is computed by dividing net income (loss) applicable to common shareholders by the weighted-average number of common shares outstanding during the period. Preferred shares, outstanding common share purchase warrants, restricted stock not yet vested or released and outstanding options are considered common stock equivalents and are only included in the calculation of diluted earnings per common share when net income is reported and their effect is dilutive. A reconciliation of the numerators and denominators is as follows (in thousands, except share and per share amounts): Three Months Ended Nine Months Ended 2020 2019 2020 2019 Numerator: Net (loss) income $ (1,190) $ 885 $ (4,239) $ (2,624) Denominator: Weighted average common shares outstanding for basic (loss) income per share 6,949,010 2,668,311 5,240,003 2,403,373 Net effect of dilutive common share equivalents — 6,241,450 — — Weighted average common shares outstanding for diluted net (loss) income per share 6,949,010 8,909,761 5,240,003 2,403,373 Net (loss) income per share: Basic $ (0.17) $ 0.33 $ (0.81) $ (1.09) Diluted $ (0.17) $ 0.10 $ (0.81) $ (1.09) Anti-dilutive common share equivalents excluded from the computation of diluted net (loss) income per share were as follows: Three Months Nine Months 2020 2019 2020 2019 Preferred shares issued and outstanding 9,355,778 — 9,355,778 5,843,778 Common share purchase warrants 2,901,182 205,687 2,901,182 205,687 Options outstanding 101,175 6,837 101,175 6,837

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Related Party Transactions In February 2020, the Company entered into a business advisory agreement (the “Torrington Advisory Agreement”) with Torrington. Under the Torrington Advisory Agreement, Torrington is to receive certain consideration in the event the Company enters into a business combination. In September 2020, the Company and Torrington entered into Amendment No. 1 to the Business Advisory Agreement (the “Torrington Amendment”). Under the Torrington Amendment, the parties agreed that if the Company closes on its merger with Rainmaker pursuant to the Agreement and Plan of Merger, dated July 14, 2020, as amended at a ratio of at least 10 Rainmaker shares for one share of the Company, Torrington shall receive 1,800,000 common shares of the Company as compensation under the Torrington Advisory Agreement, subject to regulatory and NASDAQ approvals. 1542082 Ontario Limited (“1542082 Ontario”), an investor participating in the March 23, 2020 offering, held enough common shares of the Company be classified as a related party. 1542082 Ontario acquired 120,000 common shares of the Company in the March 23, 2020 offering. In March 2020, 1542082 Ontario, paid on the Company’s behalf $150,000 directly to a business advisor for a prepayment of future services to the Company. As of September 30, 2020, 1542082 Ontario did not hold enough common shares of the Company to be classified as a related party. In October 2019, the Company entered into a conversion agreement by and among the Company, HVE and Overland under which Overland agreed to convert the following debt, accrued payables and prepayment of future goods and services into 1,600,000 Series C Preferred Shares of the Company valued at $1.00 per share: (i) principal and accrued interest of $520,000 under the Secured Promissory Note dated November 13, 2018 by and among the Company, HVE and Overland; (ii) accrued fees of $632,000 under the Transition Service Agreement (“TSA”) dated November 13, 2018 and as modified, by and among the Company and Overland; and (iii) prepayment of $448,000 for future goods and services under the TSA. As of September 30, 2020 and December 31, 2019, other current assets included $78,000 and $345,000, respectively, for prepayment of services under the TSA. In August 2019, the Company entered into agreements with certain executives of the Company and the Company’s Board of Directors to extinguish certain accrued liabilities. The Company wrote off $1.7 million of outstanding liabilities and recorded a gain on forgiveness of liabilities, which is included in other income (expense), net. In November 2018, the Company entered into a TSA to facilitate an orderly transition process for the divestiture of Overland. The TSA has terms ranging from up to 24 months depending on the service. Net expense incurred by the Company related to such agreement was approximately $74,000 and $261,000 during the three and nine months ended September 30, 2020, respectively, and $191,000 and $356,000 during the three and nine months ended September 30, 2019, respectively. As of September 30, 2020 and December 31, 2019, prepaid services included $49,000 and none, respectively, for business advisory services. As of September 30, 2020 and December 31, 2019, accrued liabilities included $40,000 and none, respectively, for business advisory service fees.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Commitments and Contingencies Letters of credit During the ordinary course of business, the Company provides standby letters of credit to third parties as required for certain transactions initiated by the Company. As of September 30, 2020, the Company had no outstanding standby letters of credit. Warranty and Extended Warranty The Company had $183,000 and $272,000 in deferred costs included in other current and non-current assets related to deferred service revenue at September 30, 2020 and December 31, 2019, respectively. Changes in the liability for product warranty and deferred revenue associated with extended warranties and service contracts were as follows (in thousands): Deferred Liability at January 1, 2020 $ 1,109 Settlements made during the period (689) Change in liability for warranties issued during the period 371 Change in liability for pre-existing warranties — Liability at September 30, 2020 $ 791 Current liability 508 Non-current liability 283 Liability at September 30, 2020 $ 791 Litigation The Company is, from time to time, subject to claims and suits arising in the ordinary course of business. In the opinion of management, the ultimate resolution of such pending proceedings will not have a material effect on the Company’s results of operations, financial position or cash flows. In January 2018, Mr. Vito Lupis filed a statement of claim in the Ontario Court of Justice alleging, among other things, breach of contracts, deceit and negligence against Mr. Giovanni J. Morelli, a former officer of the Company, and vicarious liability against the Company, in connection with stock purchase agreements and other related agreements that would have been entered into between Mr. Lupis and the Company in 2012. In March 2019, the Company and Mr. Lupis entered into a settlement agreement pursuant to which the Company has agreed to pay Mr. Lupis certain consideration, which is included in general and administrative expense, in exchange for a dismissal of the action. Currently, the Company has a judgment against it for the outstanding balance of the settlement. In April 2015, we filed a proof of claim in connection with bankruptcy proceedings of V3 Systems, Inc. (“V3”) based on breaches by V3 of the Asset Purchase Agreement entered into between V3 and the Company dated February 11, 2014 (the “APA”). On October 6, 2015, UD Dissolution Liquidating Trust (“UD Trust”), post-confirmation liquidating trust established by V3’s plan of liquidation, filed a complaint against us and certain of our current and former directors in the U.S. Bankruptcy Court for the District of Utah Central Division objecting to our proof of claim and asserting claims for affirmative relief against us and our directors. This complaint alleges, among other things, that Sphere 3D breached the APA and engaged in certain other actions and/or omissions that caused V3 to be unable to timely sell the Sphere 3D common shares received by V3 pursuant to the APA. The UD Trust seeks, among other things, monetary damages for the loss of the potential earn-out consideration, the value of the common shares held back by us pursuant to the APA and costs and fees. In March 2018, UD Trust filed a complaint in U.S. District Court for the Northern District of California (“California Complaint”) asserting that two transactions involving the Company constitute fraudulent transfers under federal and state law. First, UD Trust alleges that the consolidation of the Company’s and its subsidiaries’ indebtedness to the Cyrus Group into a debenture between FBC Holdings and the Company in December 2014 constitutes a fraudulent transfer. Second, UD Trust alleges that the Share Purchase Agreement constitutes a fraudulent transfer, and seeks to require that the proceeds of the transaction be placed in escrow until the V3 litigation is resolved. The California Complaint also asserts a claim against the Company’s former CEO for breach of fiduciary duty, and a claim against the Cyrus Group for aiding and abetting breach of fiduciary duty. On July 25, 2018, we filed a motion seeking to dismiss all of the claims asserted against the Company and its former CEO. On the same day, the Cyrus Group filed a motion seeking to dismiss all claims asserted against the Cyrus Group. The UD Trust voluntarily dismissed this case without prejudice on February 5, 2020. On October 22, 2019, UD Trust filed an amended complaint in the Delaware Bankruptcy Court. The amended complaint includes all of the claims and parties in the original complaint first filed in October 2015 in the Utah Bankruptcy Court as well as the claims and additional parties in the California Complaint. We continue to believe this lawsuit to be without merit and intend to vigorously defend against the action. On February 10, 2020, we filed a renewed motion seeking to dismiss the majority of the claims asserted by the UD Trust in the amended complaint. On that same day, we also filed a counterclaim against the UD Trust in which we allege that V3 breached numerous provisions of the APA. The Company’s current and former officers and directors that were named as defendants in the amended complaint as well as the Cyrus Group all filed motions seeking to dismiss all claims that the UD Trust alleged against them. The parties have completed briefing of these matters, have requested oral argument, and are waiting for the court to schedule argument, or decide the motion.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of ConsolidationThe condensed consolidated financial statements of the Company have been prepared by management in accordance with accounting principles generally accepted in the United States of America (“GAAP”), applied on a basis consistent for all periods. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for a complete set of financial statements. These condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on May 13, 2020. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. These condensed consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany balances and transactions have been appropriately eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of EstimatesThe preparation of the condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Significant areas requiring the use of management estimates relate to the determination of provisions for impairment assessments of goodwill, other indefinite-lived intangible assets; revenue; allowance for doubtful receivables; inventory valuation; warranty provisions; and litigation claims. Actual results could differ from these estimates.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency TranslationThe financial statements of foreign subsidiaries, for which the functional currency is the local currency, are translated into U.S. dollars using the exchange rate at the consolidated balance sheet date for assets and liabilities and a weighted-average exchange rate during the year for revenue, expenses, gains and losses. Translation adjustments are recorded as other comprehensive income (loss) within shareholders’ equity. Gains or losses from foreign currency transactions are recognized in the condensed consolidated statements of operations.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash Equivalents Highly liquid investments with insignificant interest rate risk and original maturities of three months or less, when purchased, are classified as cash equivalents. Cash equivalents are composed of money market funds. The carrying amounts approximate fair value due to the short maturities of these instruments.
Accounts Receivable [Policy Text Block]	Accounts Receivable Accounts receivable is recorded at the invoiced amount and is non-interest bearing. We estimate our allowance for doubtful accounts based on an assessment of the collectability of specific accounts and the overall condition of the accounts receivable portfolio. When evaluating the adequacy of the allowance for doubtful accounts, we analyze specific trade and other receivables, historical bad debts, customer credits, customer concentrations, customer credit-worthiness, current economic trends and changes in customers’ payment terms and/or patterns. We review the allowance for doubtful accounts on a quarterly basis and record adjustments as considered necessary. Customer accounts are written-off against the allowance for doubtful accounts when an account is considered uncollectable.
Inventories, Policy [Policy Text Block]	Inventories Inventories are stated at the lower of cost and net realizable value using the first-in-first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We assess the value of inventories periodically based upon numerous factors including, among others, expected product or material demand, current market conditions, technological obsolescence, current cost, and net realizable value. If necessary, we write down our inventory for obsolete or unmarketable inventory by an amount equal to the difference between the cost of the inventory and the net realizable value.
Investment in Affiliate [Policy Text Block]	Investment in Affiliate The Company holds an investment in equity securities of a nonpublic company for business and strategic purposes. The equity securities do not have a readily determinable fair value and are carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company reviews its investment on a regular basis to determine if the investment is impaired. For purposes of this assessment, the Company considers the investee’s cash position, earnings and revenue outlook, liquidity and management ownership, among other factors, in its review. If management’s assessment indicates that an impairment exists, the Company estimates the fair value of the equity investment and recognizes in current earnings an impairment loss that is equal to the difference between the fair value of the equity investment and its carrying amount.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill and Intangible Assets Goodwill represents the excess of consideration paid over the value assigned to the net tangible and identifiable intangible assets acquired. For intangible assets purchased in a business combination, the estimated fair values of the assets received are used to establish their recorded values. For intangible assets acquired in a non-monetary exchange, the estimated fair values of the assets transferred (or the estimated fair values of the assets received, if more clearly evident) are used to establish their recorded values. Valuation techniques consistent with the market approach, income approach and/or cost approach are used to measure fair value.
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	Impairment of Goodwill and Intangible Assets Goodwill and intangible assets are tested for impairment on an annual basis at December 31, or more frequently if there are indicators of impairment. Triggering events for impairment reviews may be indicators such as adverse industry or economic trends, restructuring actions, lower projections of profitability, or a sustained decline in our market capitalization. Intangible assets are quantitatively assessed for impairment, if necessary, by comparing their estimated fair values to their carrying values. If the carrying value exceeds the fair value, the difference is recorded as an impairment.
Revenue [Policy Text Block]	Revenue Recognition The Company accounts for revenue pursuant to ASU 2014-09, Revenue from Contracts with Customers and all the related amendments (“Topic 606”). Under Topic 606, an entity is required to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, and contract consideration will be recognized on a “sell-in basis” or when control of the purchased goods or services transfer to the distributor. The Company generates revenue primarily from: (i) solutions for standalone storage and integrated hyper-converged storage; (ii) professional services; and (iii) warranty and customer services. The Company recognizes revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the promised goods or services in the contract; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. Approximately 70% of the Company’s revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied at a point in time. These contracts are generally comprised of a single performance obligation to transfer products. Accordingly, the Company recognizes revenue when change of control has been transferred to the customer, generally at the time of shipment of products. The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically less than 45 days. Revenue on direct product sales, excluding sales to distributors, are not entitled to any specific right of return or price protection, except for any defective product that may be returned under our standard product warranty. Product sales to distribution customers that are subject to certain rights of return, stock rotation privileges and price protections, contain a component of “variable consideration.” Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products and is generally based upon a negotiated fixed price and is net of estimates for variable considerations. For performance obligations related to warranty and customer services, such as extended product warranties, the Company transfers control and recognizes revenue on a time-elapsed basis. The performance obligations are satisfied as services are rendered typically on a stand-ready basis over the contract term, which is generally 12 months. In limited circumstances where a customer is unable to accept shipment and requests products be delivered to, and stored on, the Company’s premises, also known as a “bill-and-hold” arrangement, revenue is recognized when: (i) the customer has requested delayed delivery and storage of the products, (ii) the goods are segregated from the inventory, (iii) the product is complete, ready for shipment and physical transfer to the customer, and (iv) the Company does not have the ability to use the product or direct it to another customer. The Company also enters into revenue arrangements that may consist of multiple performance obligations of its product and service offerings such as for sales of hardware devices and extended warranty services. The Company allocates contract fees to the performance obligations on a relative stand-alone selling price basis. The Company determines the stand-alone selling price based on its normal pricing and discounting practices for the specific product and/or service when sold separately. When the Company is unable to establish the individual stand-alone price for all elements in an arrangement by reference to sold separately instances, the Company may estimate the stand-alone selling price of each performance obligation using a cost plus a margin approach, by reference to third party evidence of selling price, based on the Company’s actual historical selling prices of similar items, or based on a combination of the aforementioned methodologies; whichever management believes provides the most reliable estimate of stand-alone selling price.
Standard Product Warranty, Policy [Policy Text Block]	Warranty and Extended Warranty The Company records a provision for standard warranties provided with all products. If future actual costs to repair were to differ significantly from estimates, the impact of these unforeseen costs or cost reductions would be recorded in subsequent periods.
Extended Product Warranty, Policy [Policy Text Block]	Separately priced extended on-site warranties and service contracts are offered for sale to customers on all product lines. The Company contracts with third party service providers to provide service relating to on-site warranties and service contracts. Extended warranty and service contract revenue and amounts paid in advance to outside service organizations are deferred and recognized as service revenue and cost of service, respectively, over the period of the service agreement. The Company will typically apply the practical expedient to agreements wherein the period between transfer of any good or service in the contract and when the customer pays for that good or service is one year or less. Advanced payments for long-term maintenance and warranty contracts do not give rise to a significant financing component. Rather, such payments are required by the Company primarily for reasons other than the provision of finance to the entity.
Research and Development Expense, Policy [Policy Text Block]	Research and Development CostsResearch and development expenses include payroll, employee benefits, share-based compensation expense, and other headcount-related expenses associated with product development. Research and development expenses also include third-party development and programming costs.
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income (Loss) Comprehensive income (loss) and its components encompass all changes in equity other than those arising from transactions with shareholders, including net loss and foreign currency translation adjustments, and is disclosed in a separate condensed consolidated statement of comprehensive loss.
Share-based Payment Arrangement [Policy Text Block]	Share-based Compensation We account for share-based awards, and similar equity instruments, granted to employees, non-employee directors, and consultants under the fair value method. Share-based compensation award types include stock options and restricted stock. We use the Black-Scholes option pricing model to estimate the fair value of option awards on the measurement date, which generally is the date of grant. The expense is recognized over the requisite service period (usually the vesting period) for the estimated number of instruments for which service is expected to be rendered. The fair value of restricted stock units (“RSUs”) is estimated based on the market value of the Company’s common shares on the date of grant. The fair value of options granted to non-employees is estimated at the measurement date using the Black-Scholes option pricing model. Share-based compensation expense for options with graded vesting is recognized pursuant to an accelerated method. Share-based compensation expense for RSUs is recognized over the vesting period using the straight-line method. Share-based compensation expense for an award with performance conditions is recognized when the achievement of such performance conditions are determined to be probable. If the outcome of such performance condition is not determined to be probable or is not met, no compensation expense is recognized and any previously recognized compensation expense is reversed. Forfeitures are recognized in share-based compensation expense as they occur. We have not recognized, and do not expect to recognize in the near future, any tax benefit related to share-based compensation cost as a result of the full valuation allowance of our net deferred tax assets and its net operating loss carryforward.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) that are adopted by the Company as of the specified effective date. If not discussed, the Company believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s consolidated financial statements upon adoption. Recently Adopted Accounting Pronouncements In August 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-13, Fair Value Measurement (Topic 820) (“ASU 2018-13”) . The new guidance removes, modifies and adds to certain disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement. The update is effective for annual reporting periods, including interim periods, beginning after December 15, 2019. The adoption of the new standard did not have an effect on our financial position, results of operations or cash flows. In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350) - Simplifying the Test for Goodwill Impairment (“ASU 2017-04”) . The update simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. An entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, if applicable. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The same impairment test also applies to any reporting unit with a zero or negative carrying amount. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The update is effective for annual reporting periods, including interim periods, beginning after December 15, 2019, on a prospective basis. The adoption of the new standard did not have an effect on our financial position, results of operations or cash flows.

Certain Balance Sheet Items (Ta

Certain Balance Sheet Items (Tables)	9 Months Ended
	Sep. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Schedule of Inventory, Current [Table Text Block]	The following table summarizes inventories (in thousands): September 30, December 31, Raw materials $ 120 $ 92 Work in process 166 137 Finished goods 373 524 $ 659 $ 753
Schedule of Other Current Assets [Table Text Block]	The following table summarizes other current assets (in thousands): September 30, December 31, Prepaid services $ 632 $ 23 Prepaid insurance 169 184 Transition service agreement 78 345 Deferred cost - service contracts 108 118 Other 11 — $ 998 $ 670
Schedule of Other Assets, Noncurrent [Table Text Block]	The following table summarizes other assets (in thousands): September 30, December 31, Convertible promissory note receivable long-term $ 3,128 $ — Prepaid insurance and services 418 519 Deferred cost – service contracts 75 154 Other 15 6 $ 3,636 $ 679

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	The following table summarizes intangible assets, net (in thousands): September 30, December 31, Developed technology $ 13,323 $ 13,323 Supplier agreement 1,560 — Channel partner relationships 730 730 Capitalized development costs (1) 2,959 3,047 Customer relationships 380 380 18,952 17,480 Accumulated amortization: Developed technology (13,038) (12,682) Supplier agreement (17) — Channel partner relationships (446) (355) Capitalized development costs (1) (2,303) (2,094) Customer relationships (337) (328) (16,141) (15,459) Total finite-lived assets, net 2,811 2,021 Indefinite-lived intangible assets - trade names 280 280 Total intangible assets, net $ 3,091 $ 2,301 ________________

Share Capital (Tables)

Share Capital (Tables)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Schedule of Warrants [Table Text Block]	At September 30, 2020, the Company had the following outstanding warrants to purchase common shares: Date issued Contractual life (years) Exercise price Number outstanding Expiration October 2015 5 $466.00 2,010 October 14, 2020 December 2015 5 $500.00 5,138 December 15, 2020 December 2015 5 $216.00 7,500 December 4, 2020 March 2016 5 $500.00 150 March 4, 2021 August 2017 5 $42.00 37,500 August 11, 2022 August 2017 5 $42.00 11,876 August 16, 2022 August 2017 5 $42.00 25,625 August 22, 2022 April 2018 5 $5.60 111,563 April 17, 2023 March 2020 3 $0.60 1,005,820 March 23, 2023 April 2020 5 $0.92 1,694,000 April 30, 2025 2,901,182 (1) _______________ (1) Includes warrants to purchase up to 2,002,000 common shares, in the aggregate, outstanding to related parties at September 30, 2020.

Equity Incentive Plan (Tables)

Equity Incentive Plan (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	The Company recorded the following compensation expense related to its share-based compensation awards: Three Months Nine Months 2020 2019 2020 2019 Cost of sales $ — $ — $ — $ 205 Sales and marketing — 192,446 2,014 271,763 Research and development — 15,705 2,532 52,326 General and administrative — 29,607 — 153,663 Total share-based compensation expense $ — $ 237,758 $ 4,546 $ 477,957

Net (Loss) Income Per Share (Ta

Net (Loss) Income Per Share (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Schedule of Weighted Average Number of Shares	A reconciliation of the numerators and denominators is as follows (in thousands, except share and per share amounts): Three Months Ended Nine Months Ended 2020 2019 2020 2019 Numerator: Net (loss) income $ (1,190) $ 885 $ (4,239) $ (2,624) Denominator: Weighted average common shares outstanding for basic (loss) income per share 6,949,010 2,668,311 5,240,003 2,403,373 Net effect of dilutive common share equivalents — 6,241,450 — — Weighted average common shares outstanding for diluted net (loss) income per share 6,949,010 8,909,761 5,240,003 2,403,373 Net (loss) income per share: Basic $ (0.17) $ 0.33 $ (0.81) $ (1.09) Diluted $ (0.17) $ 0.10 $ (0.81) $ (1.09)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Anti-dilutive common share equivalents excluded from the computation of diluted net (loss) income per share were as follows: Three Months Nine Months 2020 2019 2020 2019 Preferred shares issued and outstanding 9,355,778 — 9,355,778 5,843,778 Common share purchase warrants 2,901,182 205,687 2,901,182 205,687 Options outstanding 101,175 6,837 101,175 6,837

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of Product Warranty Liability [Table Text Block]	Changes in the liability for product warranty and deferred revenue associated with extended warranties and service contracts were as follows (in thousands): Deferred Liability at January 1, 2020 $ 1,109 Settlements made during the period (689) Change in liability for warranties issued during the period 371 Change in liability for pre-existing warranties — Liability at September 30, 2020 $ 791 Current liability 508 Non-current liability 283 Liability at September 30, 2020 $ 791

Organization and Business Going

Organization and Business Going Concern (Details)	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern, Conditions or Events	Based upon the Company's current expectations and projections for the next year, the Company believes that it may not have sufficient liquidity necessary to sustain operations beyond December 31, 2020. These factors, among others, raise substantial doubt that the Company will be able to continue as a going concern

Organization and Business Rainm

Organization and Business Rainmaker (Details) - USD ($)	Jul. 14, 2020	Sep. 30, 2020	Oct. 01, 2020	Aug. 04, 2020	May 04, 2020
Subsequent Event [Line Items]
Promissory note funded			$ 1,850,000
Note receivable due date		Sep. 14, 2023
Business Combination, Consideration Transferred	$ 15,000,000
Business Acquisition, Effective Date of Acquisition	Dec. 31, 2020
Business Acquisition, Equity Interest Issued or Issuable, Description		Under the Rainmaker Amendment, the ratio of the Company’s common shares to be received by Rainmaker shareholders has changed from one-third of a common share of the Company per common or preferred share of Rainmaker to 1/15 of a share.
Promissory note receivable		$ 3,100,000		$ 150,000	$ 1,100,000
Stated interest rate				10.00%

Significant Accounting Polici_3

Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Foreign Currency Transaction Loss	$ 8,000	$ 5,000	$ 9,000	$ 13,000

Significant Accounting Polici_4

Significant Accounting Policies Intangible Assets (Details)	9 Months Ended
	Sep. 30, 2020
Supplier
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	15 years
Channel partner relationships [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	6 years
Channel partner relationships [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	25 years
Developed Technology Rights [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years
Developed Technology Rights [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	9 years
Capitalized Development [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years
Capitalized Development [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	8 years
Customer Relationships [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Customer Relationships [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	25 years

Certain Balance Sheet Items Inv

Certain Balance Sheet Items Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Inventory [Line Items]
Raw Materials	$ 120	$ 92
Work in Process	166	137
Finished Goods	373	524
Inventories	$ 659	$ 753

Certain Balance Sheet Items Oth

Certain Balance Sheet Items Other current assets (Details) - USD ($)	Sep. 30, 2020	Jun. 01, 2020	Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expense	$ 632,000	$ 150,000	$ 23,000
Prepaid Insurance	169,000		184,000
Transition service agreement	78,000		345,000
Deferred Costs - service contracts	108,000		118,000
Other	11,000		0
Other Assets, Current	$ 998,000		$ 670,000

Certain Balance Sheet Items O_2

Certain Balance Sheet Items Other long term assets (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Convertible promissory note receivable long-term	$ 3,128	$ 0
Prepaid insurance and services	418	519
Deferred Costs - service contracts	75	154
Other	15	6
Other Assets	$ 3,636	$ 679

Intangible Assets Intangible As

Intangible Assets Intangible Assets (Details) - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 18,952	$ 17,480
Finite-Lived Intangible Assets, Accumulated Amortization		(16,141)	(15,459)
Finite-Lived Intangible Assets, Net		2,811	2,021
Indefinite-lived Intangible Assets (Excluding Goodwill)		280	280
Intangible Assets, Net		3,091	2,301
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		13,323	13,323
Finite-Lived Intangible Assets, Accumulated Amortization		(13,038)	(12,682)
Supplier
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		1,560	0
Finite-Lived Intangible Assets, Accumulated Amortization		(17)	0
Channel partner relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		730	730
Finite-Lived Intangible Assets, Accumulated Amortization		(446)	(355)
Capitalized Development [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[1]	2,959	3,047
Finite-Lived Intangible Assets, Accumulated Amortization	[1]	(2,303)	(2,094)
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		380	380
Finite-Lived Intangible Assets, Accumulated Amortization		$ (337)	$ (328)
[1]	Includes the impact of foreign currency exchange rate fluctuations.

Intangible Assets Amortization

Intangible Assets Amortization (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 258,000	$ 252,000	$ 740,000	$ 771,000
Amortization Expense, Remainder of Fiscal Year	228,000		228,000
Amortization Expense 2021	606,000		606,000
Amortization Expense 2022	459,000		459,000
Amortization Expense 2023	138,000		138,000
Amortization Expense 2024	116,000		116,000
Amortization Expense 2025	$ 115,000		$ 115,000

Invest 101 (Details)

Invest 101 (Details)	Aug. 03, 2020USD ($)$ / sharesshares
Goodwill and Intangible Assets Disclosure [Abstract]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	480,000
Business Acquisition, Share Price | $ / shares	$ 3.25
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | $	$ 1,560,000
Business acquisition shares hold back period	6 months
Business acquisition shares hold back	96,000

Investment in Affiliate (Detail

Investment in Affiliate (Details) - USD ($) $ in Millions	Nov. 13, 2018	Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Investments in and Advances to Affiliates, Balance, Shares	1,879,699
Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest after Disposal	19.90%
Disposal Group, Including Discontinued Operation, Consideration	$ 2.1
Investments in and Advances to Affiliates, Additional Information		no known identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment
Related Party Transaction, Description of Transaction		FBC Holdings the right to exchange up to 2,500,000 of the Company’s Series B Preferred Shares held by FBC Holdings for up to all of the SVTP Preferred Shares held by the Company (the “Exchange Right”), with such Exchange Right expiring within two years of the November 2018 closing

OMM debt (Details)

OMM debt (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Secured Debt, Current	$ 1,103,000	$ 0
Short-term Debt, Percentage Bearing Fixed Interest Rate	1.68%
Debt Instrument, Maturity Date	Dec. 30, 2020
Extinguishment of Debt, Amount	$ 600,000

Oasis Debt (Details)

Oasis Debt (Details) - USD ($)	Jul. 28, 2020	Sep. 30, 2020	Jun. 19, 2020	Jun. 16, 2020	Jun. 01, 2020
Related Party Transaction [Line Items]
Shares, Issued			150,000	200,000	100,000
Beneficial Owner [Member]
Related Party Transaction [Line Items]
Proceeds from Issuance of Debt	$ 500,000
Related Party Transaction, Rate	8.00%
Debt Instrument, Term	6 months
Notes Payable, Related Parties	$ 615,000
Shares, Issued	90,000
Share Price	$ 3.37
Debt Issuance Costs, Gross	$ 40,000
Debt Issuance Costs, Net		$ 271,000
Debt Instrument, Fair Value Disclosure		$ 311,000

Debt PPP Loan (Details)

Debt PPP Loan (Details)	Apr. 09, 2020USD ($)
Debt Disclosure [Abstract]
Covid-19 PPP Funds	$ 667,400
Covid-19 PPP Funds Interest Rate	1.00%
Covid-19 PPP Funds Repayment Period	2 years

Debt Convertible Debenture (Det

Debt Convertible Debenture (Details)	Apr. 30, 2020	Mar. 23, 2020USD ($)shares	Sep. 30, 2020USD ($)shares	Sep. 30, 2019USD ($)	Jun. 01, 2020USD ($)	Apr. 21, 2020USD ($)	Dec. 31, 2019USD ($)
Related Party Transaction [Line Items]
Subscription Agreement Units		725
Prepaid business advisory services			$ 632,000		$ 150,000		$ 23,000
Debt Conversion, Converted Instrument, Amount			$ 783,000	$ 0
Debt Conversion, Converted Instrument, Shares Issued | shares			1,206,545
Convertible Debt		$ 725,000
Debt Instrument, Convertible, Terms of Conversion Feature		each Unit consisting of (a) a 6.0% convertible debenture in the principal amount of $1,000, which is convertible at $0.6495 per share into 1,540 common shares of the Company, and (b) a warrant to purchase 1,540 common shares of the Company exercisable at any time on or before the third year anniversary date at an exercise price of $0.60 per share
Warrant blocker, ownership not to exceed	5.00%	5.00%
Proceeds from Convertible Debt		$ 575,000	$ 375,000	0
Shares Issued, Warrants Exercised | shares			200,000
Proceeds from Warrant Exercises			$ 120,000	$ 0
Related Party [Member]
Related Party Transaction [Line Items]
Subscription Agreement Units		200
Fund raise fees paid in common shares		$ 58,000
Commons shares issued for payment of services | shares		89,320
Warrant issued for payment of fee | shares		89,320
Prepaid business advisory services		$ 150,000				$ 150,000
Debt Conversion, Converted Instrument, Amount			$ 408,000
Convertible debt, shares issued to related parties | shares			628,320

Debt Line of credit (Details)

Debt Line of credit (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Line of Credit Facility, Maximum Borrowing Capacity	$ 500,000
Line of Credit Facility, Interest Rate at Period End	6.50%
Line of Credit Facility, Expiration Date	Dec. 31, 2020
Line of credit	$ 489,000	$ 491,000

Preferred Shares Series E (Deta

Preferred Shares Series E (Details) - USD ($) $ in Thousands	Sep. 17, 2020	Jul. 14, 2020	May 06, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 14, 2020	Apr. 30, 2020	Aug. 13, 2019	Jul. 12, 2019
Other Liabilities Disclosure [Abstract]
Convertible Preferred Stock, Terms of Conversion	Each Series E Preferred Share shall have a stated value of $1,000 and is convertible into the Company’s common shares at a conversion price equal to the lower of (i) 80% of the average of the three lowest VWAPs of the common stock during the ten trading days immediately preceding, but not including, the conversion date and (ii) $2.00; however, in no event shall the conversion price be lower than $1.00 per share.	Series B Preferred Shares (i) are convertible into the Company’s common shares, subject to prior shareholder approval, at a conversion rate equal to $1.00 per share, plus accrued and unpaid dividends, divided by an amount equal to 0.85 multiplied by a 15-day volume weighted average price per common share prior to the date the conversion notice is provided (the “Conversion Rate”), subject to a conversion price floor of $0.80	Each shareholder of the Series D Preferred Shares, may, at any time, convert all or any part of the Series D Preferred Shares provided that after such conversion the common shares issuable, together with all the common shares held by the shareholder in the aggregate would not exceed 9.9% of the total number of outstanding common shares of the Company or in the aggregate no more than the exchange cap of 800,000 common shares by all holders of Series D Preferred Shares.	Series E Preferred Shares, may, at any time, convert all or any Series E Preferred Shares provided that (i) the common shares issuable upon such conversion, together with all other common shares of the Company held by the shareholder in the aggregate, would not cause such shareholder’s ownership of the Company’s common shares to exceed 9.99% of the total number of outstanding common shares of the Company (ii) and such conversion would not exceed the maximum number of Sphere common shares that may be issued upon conversion of all shares of Series E Preferred Stock in the aggregate of 1,500,000 common shares
Preferred Stock, Dividend Rate, Percentage				8.00%
Preferred Shares, Shares Issued		6,500,000				3,000	1,694,000	343,778	6,500,000
Proceeds from Issuance of Preferred Stock and Preference Stock				$ 2,735	$ 0
Related Party [Member]
Other Liabilities Disclosure [Abstract]
Payments of Stock Issuance Costs				240
Related Party Transaction [Line Items]
Payments of Stock Issuance Costs				$ 240

Preferred Shares Series D (Deta

Preferred Shares Series D (Details) - USD ($)	Sep. 17, 2020	Jul. 14, 2020	May 06, 2020	Apr. 30, 2020	Mar. 23, 2020	Sep. 30, 2020	Sep. 14, 2020	Apr. 21, 2020	Aug. 13, 2019	Jul. 12, 2019
Related Party Transaction [Line Items]
Preferred Stock, Redemption Price Per Share			$ 0.65
Convertible Preferred Stock, Terms of Conversion	Each Series E Preferred Share shall have a stated value of $1,000 and is convertible into the Company’s common shares at a conversion price equal to the lower of (i) 80% of the average of the three lowest VWAPs of the common stock during the ten trading days immediately preceding, but not including, the conversion date and (ii) $2.00; however, in no event shall the conversion price be lower than $1.00 per share.	Series B Preferred Shares (i) are convertible into the Company’s common shares, subject to prior shareholder approval, at a conversion rate equal to $1.00 per share, plus accrued and unpaid dividends, divided by an amount equal to 0.85 multiplied by a 15-day volume weighted average price per common share prior to the date the conversion notice is provided (the “Conversion Rate”), subject to a conversion price floor of $0.80	Each shareholder of the Series D Preferred Shares, may, at any time, convert all or any part of the Series D Preferred Shares provided that after such conversion the common shares issuable, together with all the common shares held by the shareholder in the aggregate would not exceed 9.9% of the total number of outstanding common shares of the Company or in the aggregate no more than the exchange cap of 800,000 common shares by all holders of Series D Preferred Shares.			Series E Preferred Shares, may, at any time, convert all or any Series E Preferred Shares provided that (i) the common shares issuable upon such conversion, together with all other common shares of the Company held by the shareholder in the aggregate, would not cause such shareholder’s ownership of the Company’s common shares to exceed 9.99% of the total number of outstanding common shares of the Company (ii) and such conversion would not exceed the maximum number of Sphere common shares that may be issued upon conversion of all shares of Series E Preferred Stock in the aggregate of 1,500,000 common shares
Preferred Shares, Shares Issued		6,500,000		1,694,000			3,000		343,778	6,500,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,694,000
Loans Receivable with Fixed Rates of Interest				$ 1,100,000
Exercise Price of Warrants				$ 0.92
Warrants and Rights Outstanding, Term				5 years
Warrant blocker, ownership not to exceed				5.00%	5.00%
Preferred shares exchanged						785,000				6,500,000
Convertible Preferred Stock, Shares Issued upon Conversion						785,000
Beneficial Owner [Member]
Related Party Transaction [Line Items]
Preferred Shares, Shares Issued				847,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				847,000
Loans Receivable with Fixed Rates of Interest				$ 550,000
Convertible Preferred Stock, Shares Issued upon Conversion						485,000
Share purchase agreement, shares								211,745

Preferred Shares Series C (Deta

Preferred Shares Series C (Details) - $ / shares	Sep. 17, 2020	Jul. 14, 2020	May 06, 2020	Sep. 30, 2020	Sep. 14, 2020	Apr. 30, 2020	Oct. 31, 2019	Aug. 13, 2019	Jul. 12, 2019
Related Party Transaction [Line Items]
Convertible Preferred Stock, Terms of Conversion	Each Series E Preferred Share shall have a stated value of $1,000 and is convertible into the Company’s common shares at a conversion price equal to the lower of (i) 80% of the average of the three lowest VWAPs of the common stock during the ten trading days immediately preceding, but not including, the conversion date and (ii) $2.00; however, in no event shall the conversion price be lower than $1.00 per share.	Series B Preferred Shares (i) are convertible into the Company’s common shares, subject to prior shareholder approval, at a conversion rate equal to $1.00 per share, plus accrued and unpaid dividends, divided by an amount equal to 0.85 multiplied by a 15-day volume weighted average price per common share prior to the date the conversion notice is provided (the “Conversion Rate”), subject to a conversion price floor of $0.80	Each shareholder of the Series D Preferred Shares, may, at any time, convert all or any part of the Series D Preferred Shares provided that after such conversion the common shares issuable, together with all the common shares held by the shareholder in the aggregate would not exceed 9.9% of the total number of outstanding common shares of the Company or in the aggregate no more than the exchange cap of 800,000 common shares by all holders of Series D Preferred Shares.	Series E Preferred Shares, may, at any time, convert all or any Series E Preferred Shares provided that (i) the common shares issuable upon such conversion, together with all other common shares of the Company held by the shareholder in the aggregate, would not cause such shareholder’s ownership of the Company’s common shares to exceed 9.99% of the total number of outstanding common shares of the Company (ii) and such conversion would not exceed the maximum number of Sphere common shares that may be issued upon conversion of all shares of Series E Preferred Stock in the aggregate of 1,500,000 common shares
Preferred Shares Converted to Common Shares ownership maximum				19.90%
Preferred Shares, Shares Issued		6,500,000			3,000	1,694,000		343,778	6,500,000
Series C Preferred Stock [Member]
Related Party Transaction [Line Items]
Convertible Preferred Stock, Terms of Conversion				Overland, a related party and the sole shareholder of the Series C Preferred Shares, agreed that it would not exercise its conversion right with respect to its Series C Preferred Shares until the earlier of (i) October 31, 2020 and (ii) such time that we file for bankruptcy or an involuntary petition for bankruptcy is filed against us (unless such petition is dismissed or discharged within 30 days)
Preferred Shares Converted to Common Shares ownership maximum				19.90%
Preferred Shares, Shares Issued				1,600,000			1,600,000
Preferred Stock, Par or Stated Value Per Share				$ 1			$ 1

Preferred Shares Series B (Deta

Preferred Shares Series B (Details) - USD ($)	Sep. 17, 2020	Jul. 14, 2020	May 06, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 14, 2020	Apr. 30, 2020	Aug. 13, 2019	Jul. 12, 2019
Equity [Abstract]
Preferred shares exchanged				785,000		785,000					6,500,000
Preferred Shares, Shares Issued		6,500,000						3,000	1,694,000	343,778	6,500,000
Preferred Stock, Reason why Security is Not Redeemable						Pursuant to the terms of the Lock-up Agreement, FBC has agreed that for the period of time between (a) July 14, 2020 and (b) the earlier to occur of (i) April 30, 2021 and (ii) the date that is 180 days after a Change of Control (as defined in the Lock-up Agreement), it will not without the prior written consent of the Company convert any of the Series B Preferred Shares into common shares of the Company
Preferred Stock, Value, Issued										$ 343,778
Dividends				$ 0	$ 30,000	$ 0	$ 291,000
Convertible Preferred Stock, Terms of Conversion	Each Series E Preferred Share shall have a stated value of $1,000 and is convertible into the Company’s common shares at a conversion price equal to the lower of (i) 80% of the average of the three lowest VWAPs of the common stock during the ten trading days immediately preceding, but not including, the conversion date and (ii) $2.00; however, in no event shall the conversion price be lower than $1.00 per share.	Series B Preferred Shares (i) are convertible into the Company’s common shares, subject to prior shareholder approval, at a conversion rate equal to $1.00 per share, plus accrued and unpaid dividends, divided by an amount equal to 0.85 multiplied by a 15-day volume weighted average price per common share prior to the date the conversion notice is provided (the “Conversion Rate”), subject to a conversion price floor of $0.80	Each shareholder of the Series D Preferred Shares, may, at any time, convert all or any part of the Series D Preferred Shares provided that after such conversion the common shares issuable, together with all the common shares held by the shareholder in the aggregate would not exceed 9.9% of the total number of outstanding common shares of the Company or in the aggregate no more than the exchange cap of 800,000 common shares by all holders of Series D Preferred Shares.			Series E Preferred Shares, may, at any time, convert all or any Series E Preferred Shares provided that (i) the common shares issuable upon such conversion, together with all other common shares of the Company held by the shareholder in the aggregate, would not cause such shareholder’s ownership of the Company’s common shares to exceed 9.99% of the total number of outstanding common shares of the Company (ii) and such conversion would not exceed the maximum number of Sphere common shares that may be issued upon conversion of all shares of Series E Preferred Stock in the aggregate of 1,500,000 common shares
Preferred Stock, Dividend Rate, Percentage						8.00%
Change of control trigger				20.00%		20.00%
Preferred Shares Converted to Common Shares ownership maximum						19.90%

Share Capital Group P (Details)

Share Capital Group P (Details) - USD ($)	Jun. 19, 2020	Jun. 16, 2020	Jun. 01, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Prepaid Expense			$ 150,000	$ 632,000		$ 23,000
Shares, Issued	150,000	200,000	100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			50,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price			$ 2.52
Award Vesting Period			6 months
Stock Issued	$ 360,000	$ 504,000		$ 2,034,000	$ 105,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period			100,000	400,841	42,000

Share Capital ROK Consulting (D

Share Capital ROK Consulting (Details) - USD ($)	Jun. 19, 2020	Jun. 16, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 01, 2020	Apr. 24, 2020
Equity [Abstract]
Shares to be issued in lieu of cash			1,800,000			375,000
Shares, Issued	150,000	200,000			100,000
Stock Issued	$ 360,000	$ 504,000	$ 2,034,000	$ 105,000

Share Capital Oasis Capital (De

Share Capital Oasis Capital (Details) - USD ($)	Aug. 04, 2020	Jun. 19, 2020	Jun. 16, 2020	May 15, 2020	Oct. 31, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 01, 2020
Related Party Transaction [Line Items]
Stock Issued		$ 360,000	$ 504,000			$ 2,034,000	$ 105,000
Shares, Issued		150,000	200,000					100,000
Related Party [Member]
Related Party Transaction [Line Items]
Stock Issued	$ 725,000					$ 140,000
Equity purchase agreement				$ 11,000,000
Equity purchase agreement term				36 months
Minimum floor price				$ 1.58
Shares, Issued	225,000					60,000
Related Party [Member] | Subsequent Event [Member]
Related Party Transaction [Line Items]
Stock Issued					$ 249,000
Shares, Issued					140,000

Share Capital Oct 2019 (Details

Share Capital Oct 2019 (Details) - USD ($)	Sep. 30, 2020	May 26, 2020	Apr. 21, 2020	Dec. 31, 2019	Oct. 09, 2019
Equity [Abstract]
Common Shares, Issued	7,597,186			3,850,105	149,500
Shares Issued, Price Per Share					$ 1.19
Share Purchase Agreement, value		$ 299,000	$ 153,000

Share Capital Related Party Sha

Share Capital Related Party Share Purchase Agreement (Details) - USD ($)	Sep. 30, 2020	May 26, 2020	Apr. 21, 2020	Dec. 31, 2019	Oct. 30, 2019	Oct. 09, 2019
Related Party Transaction [Line Items]
Common Shares, Issued	7,597,186			3,850,105		149,500
Shares Issued, Price Per Share						$ 1.19
Share Purchase Agreement, value		$ 299,000	$ 153,000
Related Party [Member]
Related Party Transaction [Line Items]
Common Shares, Issued					330,000
Shares Issued, Price Per Share					$ 1.07

Share Capital Private Placement

Share Capital Private Placement (Details) - USD ($)	Aug. 15, 2019	Mar. 31, 2020	Sep. 30, 2020	Sep. 30, 2019	Oct. 09, 2019
Sale of Stock [Line Items]
Shares Issued, Price Per Share					$ 1.19
Proceeds from Issuance of Common Shares, private placement			$ 115,000	$ 480,000
Private Placement [Member]
Sale of Stock [Line Items]
Stock Issued During Period, Shares, Period Increase (Decrease)	251,823	175,765
Shares Issued, Price Per Share	$ 1.29
Proceeds from Issuance of Common Shares, private placement	$ 325,000
Common shares not issued			76,058

Share Capital Warrants Outstand

Share Capital Warrants Outstanding (Details) - $ / shares	9 Months Ended
	Sep. 30, 2020	Apr. 30, 2020
Class of Warrant or Right [Line Items]
Exercise Price of Warrants		$ 0.92
Related Party [Member]
Class of Warrant or Right [Line Items]
Warrant, Outstanding	2,002,000
October 14, 2020 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 466
Warrant, Outstanding	2,010
Warrant expiration date	Oct. 14, 2020
December 15, 2020 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 500
Warrant, Outstanding	5,138
Warrant expiration date	Dec. 15, 2020
December 4, 2020 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 216
Warrant, Outstanding	7,500
Warrant expiration date	Dec. 4, 2020
March 4, 2021 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 500
Warrant, Outstanding	150
Warrant expiration date	Mar. 4, 2021
August 11, 2022 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 42
Warrant, Outstanding	37,500
Warrant expiration date	Aug. 11, 2022
August 16, 2022 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 42
Warrant, Outstanding	11,876
Warrant expiration date	Aug. 16, 2022
August 22, 2022 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 42
Warrant, Outstanding	25,625
Warrant expiration date	Aug. 22, 2022
April 17, 2023 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 5.60
Warrant, Outstanding	111,563
Warrant expiration date	Apr. 17, 2023
March 23, 2023 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	3 years
Exercise Price of Warrants	$ 0.60
Warrant, Outstanding	1,005,820
Warrant expiration date	Mar. 23, 2023
April 30, 2025 [Member]
Class of Warrant or Right [Line Items]
Warrant Term	5 years
Exercise Price of Warrants	$ 0.92
Warrant, Outstanding	1,694,000
Warrant expiration date	Apr. 30, 2025
Warrant [Member]
Class of Warrant or Right [Line Items]
Warrant, Outstanding	2,901,182

Equity Incentive Plan Textuals

Equity Incentive Plan Textuals (Details) - USD ($)	Jun. 01, 2020	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units and Stock Options Vesting Period	6 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	50,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 2.52
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period		0	100,000
RSUs Outside of 2015 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period			100,000
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units and Stock Options Vesting Period		3 years
Share-based Payment Arrangement, Nonemployee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		130,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price		$ 2.52
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period	100,000	400,841	42,000
RSAs, Share-based Third Party Liabilities Paid		$ 771,000	$ 105,000
Beneficial Owner [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		30,000

Equity Incentive Plan Share-bas

Equity Incentive Plan Share-based Compensation Expense (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	$ 0	$ 237,758	$ 4,546	$ 477,957
Cost of Sales [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	0	0	0	205
Sales and Marketing Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	0	192,446	2,014	271,763
Research and Development Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	0	15,705	2,532	52,326
General and Administrative Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	$ 0	$ 29,607	$ 0	$ 153,663

Equity Incentive Plan (Details)

Equity Incentive Plan (Details)	Sep. 30, 2020USD ($)
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 0

Net (Loss) Income Per Share (De

Net (Loss) Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Earnings Per Share [Abstract]
Weighted Average Number of Shares Outstanding, Basic and Diluted	6,949,010			2,668,311			5,240,003	2,403,373
Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares	0			6,241,450			0	0
Weighted Average Number of Shares Outstanding, Diluted	6,949,010			8,909,761			5,240,003	2,403,373
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.17)			$ 0.33			$ (0.81)	$ (1.09)
Income (Loss) from Continuing Operations, Per Diluted Share	$ (0.17)			$ 0.10			$ (0.81)	$ (1.09)
Net Loss	$ (1,190)	$ (1,946)	$ (1,103)	$ 885	$ (1,665)	$ (1,844)	$ (4,239)	$ (2,624)

Net (Loss) Income Per Share Net

Net (Loss) Income Per Share Net Loss Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	9,355,778	0	9,355,778	5,843,778
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,901,182	205,687	2,901,182	205,687
Share-based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	101,175	6,837	101,175	6,837

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Oct. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 14, 2020	Jul. 14, 2020	Jun. 01, 2020	Apr. 30, 2020	Apr. 24, 2020	Apr. 21, 2020	Mar. 23, 2020	Dec. 31, 2019	Aug. 13, 2019	Jul. 12, 2019
Related Party Transaction [Line Items]
Prepaid Expense		$ 632,000		$ 632,000				$ 150,000					$ 23,000
Preferred Shares, Shares Issued						3,000	6,500,000		1,694,000					343,778	6,500,000
Related Party Transaction, Amounts of Transaction		74,000	$ 191,000	261,000	$ 356,000
Related Party Transaction, Due from (to) Related Party, Current		49,000		49,000									0
Due from Related Parties, Current		78,000		78,000									345,000
Due to Other Related Parties		$ 40,000		$ 40,000									$ 0
Shares to be issued in lieu of cash		1,800,000		1,800,000						375,000
Series C Preferred Stock [Member]
Related Party Transaction [Line Items]
Preferred Shares, Shares Issued	1,600,000	1,600,000		1,600,000
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1		$ 1
Debt [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction	$ 520,000
Accrued Liabilities [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction	632,000
Prepaid Expenses and Other Current Assets [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction	$ 448,000
Related Party [Member]
Related Party Transaction [Line Items]
Share purchase agreement, shares											120,000
Prepaid Expense											$ 150,000	$ 150,000

Commitments and Contingencies_2

Commitments and Contingencies (Details)	Sep. 30, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
Letters of Credit Outstanding, Amount	$ 0

Commitments and Contingencies W

Commitments and Contingencies Warranty and Extended Warranty (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Deferred Costs, Service Revenue	$ 183,000	$ 272,000
Product Warranty Liability [Line Items]
Deferred revenue extended warranties, current	508,000
Deferred revenue extended warranties, noncurrent	283,000
Deferred revenue [Member]
Product Warranty Liability [Line Items]
Deferred Revenue, period start	1,109,000
Standard and Extended Product Warranty Accrual, Decrease for Payments	(689,000)
Standard and Extended Product Warranty Accrual, Increase for Warranties Issued	371,000
Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties	0
Deferred Revenue, period end	$ 791,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Oct. 26, 2020	Nov. 03, 2020	Sep. 30, 2020	Sep. 30, 2019
Subsequent Event [Line Items]
Shares Issued, Warrants Exercised			200,000
Proceeds from Warrant Exercises			$ 120,000	$ 0
Subsequent Event [Member]
Subsequent Event [Line Items]
Shares Issued, Warrants Exercised		100,000
Proceeds from Warrant Exercises		$ 60,000
Stock Issued During Period, Shares, New Issues	30,000